| Cell No. |
Cell Name |
|
| HPS0002 |
| 253G1 |
| Comment | Human iPS cell line. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 were derived from the same person. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0003 |
| HiPS-RIKEN-1A |
| Comment | Human iPS cell line. Parent cell line of RCB0436 HUC-F2. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0009 |
| HiPS-RIKEN-2A |
| Comment | Human iPS cell line. Parent cell line of RCB0197 HUC-Fm. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0014 |
| HiPS-RIKEN-2F |
| Comment | Human iPS cell line. Parent cell line of RCB0197 HUC-Fm. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0029 |
| HiPS-RIKEN-12A |
| Comment | Human iPS cell line. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0045 |
| HiPS-RIKEN-5A |
| Comment | Disease specific iPS cell line derived from a patient : Wilson's disease (RCB0395 NCU-F8). The analysis performed by RIKEN BRC indicated mutations in ATP7B gene; 2333G>T (p.R778L) in one allele and 2495A>G (p.K832R) and c.2855G>A (p.R952K) in another allele. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0046 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0395 NCU-F8). |
|---|
| Comment from the depositor | |
|---|
| HPS0047 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0395 NCU-F8). |
|---|
| Comment from the depositor | |
|---|
| HPS0048 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0395 NCU-F8). |
|---|
| Comment from the depositor | |
|---|
| HPS0049 |
| HiPS-RIKEN-7A |
| Comment | Disease specific iPS cell line derived from a patient : Wilson's disease (RCB0390 NCU-F3). The analysis performed by RIKEN BRC indicated mutations in ATP7B gene; 3104G>T (p.G1035V) in one allele and 3784G>T (p.V1262F) in another allele. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0050 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0390 NCU-F3). |
|---|
| Comment from the depositor | |
|---|
| HPS0051 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0390 NCU-F3). |
|---|
| Comment from the depositor | |
|---|
| HPS0052 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0390 NCU-F3). |
|---|
| Comment from the depositor | |
|---|
| HPS0053 |
| HiPS-RIKEN-9A |
| Comment | Disease specific iPS cell line derived from a patient : Wilson's disease (RCB0391 NCU-F4). The analysis performed by RIKEN BRC indicated mutations in ATP7B gene; 3104G>T (p.G1035V) in one allele and 3784G>T (p.V1262F) in another allele. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0054 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0391 NCU-F4). |
|---|
| Comment from the depositor | |
|---|
| HPS0055 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0391 NCU-F4). |
|---|
| Comment from the depositor | |
|---|
| HPS0056 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0391 NCU-F4). |
|---|
| Comment from the depositor | |
|---|
| HPS0057 |
| 297A1 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0058 |
| 297F1 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0059 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0060 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dementia of Alzheimer's type. HPS0060, HPS0812, HPS0813, HPS0814, HPS0815, HPS0816, HPS0817 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0061 |
| 59M8 |
| Comment | Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0062 |
| K10M5 |
| Comment | Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0063 |
| 201B7 |
| Comment | Human iPS cell line. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 were derived from the same person. Cryopreserved by vitrification method. Feeder-less 201B7 is also available as HPS4290 : 201B7-Ff. |
|---|
| Comment from the depositor | |
|---|
| HPS0064 |
|
| Comment | Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 1b. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0070 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0071 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0071 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0070 was derived from the same patient.iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0072 |
| K11PD17 |
| Comment | Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0073 |
| K21S4 |
| Comment | Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0074 |
| K31M28 |
| Comment | Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0075 |
| K32M17 |
| Comment | Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0076 |
| 409B2 |
| Comment | Human iPS cell line. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 are derived from the same person. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0077 |
| 454E2 |
| Comment | Stopped distribution temporarily. Human iPS cell line. Cryopreserved by vitrification method. Application consideration. Please see CiRA Foundation, if you are a researcher at a for-profit organization. |
|---|
| Comment from the depositor | |
|---|
| HPS0078 |
|
| Comment | Disease specific iPS cell line derived from a patient : Bernard-Soulier syndorome. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0082 |
| iPWS5 |
| Comment | Disease specific iPS cell line derived from a patient : Prader Willi syndrome (RCB1560 PWS-Yamaguchi). del(15) was found in lymphocytes of the patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0083 |
| iCK2 |
| Comment | Disease specific iPS cell line derived from a patient : Cockayne's syndrome (RCB0397 NCU-F10). HPS0085 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0085 |
| iCK10 |
| Comment | Disease specific iPS cell line derived from a patient : Cockayne's syndrome (RCB0397 NCU-F10). HPS0083 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0087 |
| iOTC4 |
| Comment | Disease specific iPS cell line derived from a patient : Ornithinetranscarbamylase deficiency (RCB0492 OTCD1TKB). iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0104 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. |
|---|
| Comment from the depositor | |
|---|
| HPS0105 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. |
|---|
| Comment from the depositor | |
|---|
| HPS0106 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. |
|---|
| Comment from the depositor | |
|---|
| HPS0107 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. |
|---|
| Comment from the depositor | |
|---|
| HPS0112 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : iPS-like cells derived from colorectal adenocarcinoma. |
|---|
| Comment from the depositor | |
|---|
| HPS0117 |
| CiRA086Ai-m1 |
| Comment | Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). Cryopreserved by vitrification method. Application consideration. |
|---|
| Comment from the depositor | |
|---|
| HPS0119 |
| CiRA188Ai-M1 |
| Comment | Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). HPS0120 was derived from the same patient. Cryopreserved by vitrification method. Application consideration. |
|---|
| Comment from the depositor | |
|---|
| HPS0120 |
| CiRA188Ai-W1 |
| Comment | Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). HPS0119 was derived from the same patient. Cryopreserved by vitrification method. Application consideration. |
|---|
| Comment from the depositor | |
|---|
| HPS0129 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (classical, with UMN). HPS0130 was derived from the same patient. iPS cells were created using the Sendai virus vector. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0130 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (classical, with UMN). HPS0129 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0133 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Miyoshi type (Miyoshi myopathy). iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0134 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (pseudo-polyneuritic, w/o UMN). iPS cells were created using the Sendai virus vector. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0136 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (pseudo-polyneuritic, w/o UMN). HPS0134 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0140 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Familial type. HPS0141 and HPS0142 were derived from the same patient. iPS cells were created using the Sendai virus vector. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0141 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Familial type. HPS0140 and HPS0142 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0142 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Familial type. HPS0140 and HPS0141 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0143 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital fiber type disproportion disease. HPS0144 and HPS0145 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0144 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital fiber type disproportion disease. HPS0143 and HPS0145 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0145 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital fiber type disproportion disease. HPS0143 and HPS0144 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0146 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (bulbar, with UMN). HPS0147 and HPS0148 were derived from the same patient. iPS cells were created using the Sendai virus vector. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0147 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (bulbar, with UMN). HPS0146 and HPS0148 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0148 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS), Sporadic type (bulbar, with UMN). HPS0146 and HPS0147 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0149 |
| iTS1 |
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Tay-Sachs' disease (RCB0697 GM2-1TKB)). iPS cells were created using the Sendai virus vector. HPS0150 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0150 |
| iTS2 |
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Tay-Sachs' disease (RCB0697 GM2-1TKB)). iPS cells were created using the Sendai virus vector. HPS0149 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0156 |
|
| Comment | Disease specific iPS cell line derived from a patient : Bardet-Biedl syndrome. HPS0157 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0157 |
|
| Comment | Disease specific iPS cell line derived from a patient : Bardet-Biedl syndrome. HPS0156 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0158 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal muscular atrophy type 1. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0159 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy, Type I. |
|---|
| Comment from the depositor | |
|---|
| HPS0164 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0169 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0171 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0171 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0169 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0174 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dermatomyositis (DM). iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0175 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pompe's disease. HPS0176 and HPS0177 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0176 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pompe's disease. HPS0175 and HPS0177 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0177 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pompe's disease. HPS0175 and HPS0176 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0178 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS0179 and HPS0180 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0179 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS0178 and HPS0180 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0180 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS0178 and HPS0179 new derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0183 |
|
| Comment | Disease specific iPS cell line derived from a patient : Inclusion body myositis. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0184 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systematic Sclerosis (SSc). HPS0185 and HPS0186 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0185 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systematic Sclerosis (SSc). HPS0184 and HPS0186 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0186 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systematic Sclerosis (SSc). HPS0184 and HPS0185 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0191 |
|
| Comment | Disease specific iPS cell line derived from a patient : Bernard-Soulier syndrome. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0192 |
|
| Comment | Disease specific iPS cell line derived from a patient : Allergic rhinitis (Pollen allergy). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0193 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Werner syndrome (RCB0407 WS2TKB). |
|---|
| Comment from the depositor | |
|---|
| HPS0200 |
|
| Comment | Disease specific iPS cell line derived from a patient :Muscular dystrophy, Limb-girdle type. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0207 |
|
| Comment | Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). HPS0208 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0208 |
|
| Comment | Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). HPS0207 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0209 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pulmonary hypertension. HPS0210 and HPS0211 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0210 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pulmonary hypertension. HPS0209 and HPS0211 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0211 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pulmonary hypertension. HPS0209 and HPS0210 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0214 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, Kosho Type. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0215 |
|
| Comment | Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0216 and HPS0217 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0216 |
|
| Comment | Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0215 and HPS0217 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0217 |
|
| Comment | Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0215 and HPS0216 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0223 |
| Nips-B2 |
| Comment | Human iPS cell line. iPS cells were created using the Sendai virus vector. Past history : atopic asthma. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0224 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0226 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0225 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. |
|---|
| Comment from the depositor | |
|---|
| HPS0226 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0224 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0227 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyloid neuropathy. HPS0228 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0228 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0227 was derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0233 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Becker type. HPS0234 was derived from the same patient.iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0234 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Becker type. HPS0233 was derived from the same patient.iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0240 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Metachromatic leukodystrophy (MLD)). iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0247 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0248 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0249 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0250 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0251 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0251, HPS1719 were derived from the same patient. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0252 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0252, HPS1720 were derived from the same patient. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0253 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0255 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0256 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0257 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0258 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0259 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0260 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0261 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0262 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0263 |
|
| Comment | Disease specific iPS cell line derived from a patient : Huntington's disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0264 |
| CiRA-PD00021 |
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0265 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0266 and HPS0267 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0266 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0265 and HPS0267 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0267 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0265 and HPS0266 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0268 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). |
|---|
| Comment from the depositor | |
|---|
| HPS0269 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). |
|---|
| Comment from the depositor | |
|---|
| HPS0270 |
|
| Comment | Disease specific iPS cell line derived from a patient : Atopic dermatitis. HPS0271 and HPS0272 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0271 |
|
| Comment | Disease specific iPS cell line derived from a patient : Atopic dermatitis. HPS0270 and HPS0272 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0272 |
|
| Comment | Disease specific iPS cell line derived from a patient : Atopic dermatitis. HPS0270 and HPS0271 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0284 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Werner syndrome (RCB0407 WS2TKB). |
|---|
| Comment from the depositor | |
|---|
| HPS0285 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Werner syndrome (RCB0407 WS2TKB). |
|---|
| Comment from the depositor | |
|---|
| HPS0287 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Werner syndrome (RCB0407 WS2TKB). |
|---|
| Comment from the depositor | |
|---|
| HPS0288 |
| iPS-WS2-C5 |
| Comment | Disease specific iPS cell line derived from a patient : Werner syndrome. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0290 |
| CiRA00022 |
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0290, HPS0291, HPS0327 were derived from the same patient. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0291 |
| CiRA00023 |
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0290, HPS0291, HPS0327 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0292 |
| CiRA00024 |
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0292, HPS0293, HPS0294, HPS1717 were derived from the same patient. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0293 |
| CiRA00025 |
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0292, HPS0293, HPS0294, HPS1717 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0294 |
| CiRA00026 |
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0292, HPS0293, HPS0294, HPS1717 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0296 |
| 32R2 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 were derived from the same person. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0312 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0313 and HPS0314 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0313 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 and HPS0314 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0314 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 and HPS0313 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0315 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. |
|---|
| Comment from the depositor | |
|---|
| HPS0316 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. |
|---|
| Comment from the depositor | |
|---|
| HPS0317 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0318, HPS0319, HPS0320, HPS0321, HPS0322, HPS0323, HPS0324, HPS0325 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0318 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). |
|---|
| Comment from the depositor | |
|---|
| HPS0319 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0318, HPS0319, HPS0320, HPS0321, HPS0322, HPS0323, HPS0324, HPS0325 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0320 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). |
|---|
| Comment from the depositor | |
|---|
| HPS0321 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). |
|---|
| Comment from the depositor | |
|---|
| HPS0322 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0318, HPS0319, HPS0320, HPS0321, HPS0322, HPS0323, HPS0324, HPS0325 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0323 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0318, HPS0319, HPS0320, HPS0321, HPS0322, HPS0323, HPS0324, HPS0325 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0324 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). |
|---|
| Comment from the depositor | |
|---|
| HPS0325 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). |
|---|
| Comment from the depositor | |
|---|
| HPS0326 |
| 32R6 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 were derived from the same person. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0327 |
| CiRA00021 |
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0290, HPS0291, HPS0327 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0328 |
| 606A1 |
| Comment | Human iPS cell line derived from a healthy individual (cord blood) . HPS0328, HPS0329 was derived from the same person. Cryopreserved by vitrification method. Please see CiRA Foundation, if you are a researcher at a for-profit organization. |
|---|
| Comment from the depositor | |
|---|
| HPS0329 |
| 606B1 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual (cord blood) . HPS0328, HPS0329 was derived from the same person. Cryopreserved by vitrification method. Please see CiRA Foundation, if you are a researcher at a for-profit organization. |
|---|
| Comment from the depositor | |
|---|
| HPS0330 |
| 610A2 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual (cord blood) . HPS0330, HPS0331 was derived from the same person. Cryopreserved by vitrification method. Please see CiRA Foundation, if you are a researcher at a for-profit organization. |
|---|
| Comment from the depositor | |
|---|
| HPS0331 |
| 610B1 |
| Comment | Human iPS cell line derived from a healthy individual (cord blood) . HPS0330, HPS0331 was derived from the same person. Cryopreserved by vitrification method. Please see CiRA Foundation, if you are a researcher at a for-profit organization. |
|---|
| Comment from the depositor | |
|---|
| HPS0332 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hypophosphatasia, perinatal type. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0333 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hypophosphatasia, perinatal type. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0334 |
|
| Comment | Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0335 and HPS0336 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0335 |
|
| Comment | Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0334 and HPS0336 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0336 |
|
| Comment | Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0334 and HPS0335 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0337 |
|
| Comment | Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0338 and HPS0339 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0338 |
|
| Comment | Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0337 and HPS0339 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0339 |
|
| Comment | Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0337 and HPS0338 were derived from the same patient. iPS cells were created using the Sendai virus vector. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0351 |
| VCP-#1 |
| Comment | Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0352 and HPS0353 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0352 |
| VCP-#2 |
| Comment | Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0353 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0353 |
| VCP-#4 |
| Comment | Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0352 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0354 |
| 585A1 |
| Comment | Human iPS cell line derived from a healthy individual (peripheral blood). Established with episomal vector. Oct3/4, Sox2, Klf4, L-Myc, Lin28 and shRNA against p53 were used for establishment. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0355 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0356 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0357 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0358 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0359 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0360 |
| 648A1 |
| Comment | Human iPS cell line derived from a healthy individual (peripheral blood)l. Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc, Lin28 and shRNA against p53 were used for establishment. Cryopreserved by vitrification method. Please see CiRA Foundation, if you are a researcher at a for-profit organization. |
|---|
| Comment from the depositor | |
|---|
| HPS0361 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0363 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease, Familial type. |
|---|
| Comment from the depositor | |
|---|
| HPS0365 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease, Familial type. |
|---|
| Comment from the depositor | |
|---|
| HPS0376 |
| CiRA00041 |
| Comment | Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP).HPS0377 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0377 |
| CiRA00042 |
| Comment | Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP).HPS0376 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0378 |
| CiRA00043 |
| Comment | Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0379 |
| 1201C1 |
| Comment | Human iPS cell line derived from a healthy individual. HPS0379, HPS0380, HPS0381, HPS4293 was derived from the same person. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0380 |
| 1205D1 |
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. HPS0379, HPS0380, HPS0381, HPS4293 was derived from the same person. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0381 |
| 1231A3 |
| Comment | Human iPS cell line derived from a healthy individual. HPS0379, HPS0380, HPS0381, HPS4293 was derived from the same person. |
|---|
| Comment from the depositor | |
|---|
| HPS0383 |
| CiRA00111 |
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (deletion of exon 44, dystrophin gene). HPS0384, HPS0385, HPS0386 and HPS0387 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0384 |
| CiRA00111-IF-D28 |
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0385, HPS0386 and HPS0387 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | To restore Dystrophin gene reading frame, one base was introduced to exon 45 by using TALEN. |
|---|
| HPS0385 |
| CiRA00111-ES-H19 |
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0386 and HPS0387 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | To restore Dystrophin gene reading frame by exon skipping, 18 bp deletion was introduced at the splicing acceptor of the exon 45 by using TALEN. |
|---|
| HPS0386 |
| CiRA00111-TKI-I15 |
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0385 and HPS0387 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | To restore Dystrophin gene, exon 44 was inserted in front of the exon 45 via TALEN mediated homologous recombination. Hygromycin resistance cassette was removed by Cre recombinase, hence a single loxP sequence remain in intron 44. |
|---|
| HPS0387 |
| CiRA00111-CKI-C2 |
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0385 and HPS0386 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | To restore Dystrophin gene, exon 44 was inserted in front of the exon 45 via CRISPR-Cas9 mediated homologous recombination. Hygromycin resistance cassette was removed by Cre recombinase, hence a single loxP sequence remain in intron 44. |
|---|
| HPS0388 |
|
| Comment | Disease specific iPS cell line derived from a patient : Achondroplasia. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0389 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Achondroplasia. |
|---|
| Comment from the depositor | |
|---|
| HPS0390 |
|
| Comment | Disease specific iPS cell line derived from a patient : Miyoshi myopathy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0391 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0392 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0393 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy, type 1. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0394 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy, type 1. |
|---|
| Comment from the depositor | |
|---|
| HPS0395 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy, type 1. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0396 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy, type 1. |
|---|
| Comment from the depositor | |
|---|
| HPS0397 |
|
| Comment | Disease specific iPS cell line derived from a patient : Miyoshi myopathy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0398 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0399 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0407 |
|
| Comment | Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. HPS1010 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0408 |
|
| Comment | Disease specific iPS cell line derived from a patient : Miyoshi myopathy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0409 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0410 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0411 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Miyoshi myopathy patient (HPS0408〜HPS0410). |
|---|
| Comment from the depositor | |
|---|
| HPS0412 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Miyoshi myopathy patient (HPS0408〜HPS0410). |
|---|
| Comment from the depositor | |
|---|
| HPS0413 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Miyoshi myopathy patient (HPS0408〜HPS0410). |
|---|
| Comment from the depositor | |
|---|
| HPS0414 |
|
| Comment | Disease specific iPS cell line derived from a patient : Primary lateral sclerosis (PLS). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0415 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary lateral sclerosis (PLS). |
|---|
| Comment from the depositor | |
|---|
| HPS0417 |
|
| Comment | Disease specific iPS cell line derived from a patient : Primary lateral sclerosis (PLS). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0418 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary lateral sclerosis (PLS). |
|---|
| Comment from the depositor | |
|---|
| HPS0419 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0420 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0421 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0422 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0424 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0425 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0426 |
| CiRA00139 |
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0427 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0428 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0429 |
| CiRA00142 |
| Comment | Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0430 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0431 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0433 |
|
| Comment | Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0434 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0437 |
|
| Comment | Disease specific iPS cell line derived from a patient : Sjögren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0438 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0439 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0440 |
|
| Comment | Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. HPS0440, HPS0441, HPS0442 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0441 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS0442 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS0443 |
|
| Comment | Disease specific iPS cell line derived from a patient : Rheumatoid arthritis. HPS0443, HPS0444, HPS0445 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0444 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS0445 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS0446 |
|
| Comment | Disease specific iPS cell line derived from a patient : Juvenile nephronophthisis. HPS0446, HPS0447, HPS0448 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0447 |
|
| Comment | Disease specific iPS cell line derived from a patient : Juvenile nephronophthisis. The analysis performed by RIKEN BRC indicated homozygous deletion from 110,852,753 (MALL gene region) to 110,986,718 (NPHP1 gene region) in Chromosome 2 (detected by CGH array). HPS0446, HPS0447, HPS0448 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0448 |
|
| Comment | Disease specific iPS cell line derived from a patient : Juvenile nephronophthisis. HPS0446, HPS0447, HPS0448 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0449 |
|
| Comment | Disease specific iPS cell line derived from a patient : Juvenile nephronophthisis. HPS0449, HPS0450, HPS0451 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0450 |
|
| Comment | Disease specific iPS cell line derived from a patient : Juvenile nephronophthisis. The analysis performed by RIKEN BRC indicated homozygous deletion from 110,852,753 (MALL gene region) to 110,986,718 (NPHP1 gene region) in Chromosome 2 (detected by CGH array). HPS0449, HPS0450, HPS0451 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0451 |
|
| Comment | Disease specific iPS cell line derived from a patient : Juvenile nephronophthisis. HPS0449, HPS0450, HPS0451 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0452 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epstein syndrome. HPS0452, HPS0453, HPS0454 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0453 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epstein syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0454 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epstein syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0455 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Epstein syndrome patient (HPS0452〜HPS0453). |
|---|
| Comment from the depositor | |
|---|
| HPS0456 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Epstein syndrome patient (HPS0452〜HPS0453). |
|---|
| Comment from the depositor | |
|---|
| HPS0457 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Epstein syndrome patient (HPS0452〜HPS0453). |
|---|
| Comment from the depositor | |
|---|
| HPS0458 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial disease. HPS0458, HPS0459, HPS0460 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0459 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial disease. HPS0458, HPS0459, HPS0460 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0460 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial disease. HPS0458, HPS0459, HPS0460 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0461 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial disease. HPS0461, HPS0462, HPS0463 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0462 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial disease. HPS0461, HPS0462, HPS0463 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0463 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mitochondrial disease. HPS0461, HPS0462, HPS0463 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0464 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0464, HPS0465, HPS0466 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0465 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0466 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0467 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0467, HPS0468, HPS0469 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0468 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0469 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0470 |
|
| Comment | Disease specific iPS cell line derived from a patient : Frontotemporal dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0471 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0472 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0473 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0474 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0475 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0476 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0476, HPS0477, HPS0478 were derived from the same patient. Analysis of causal genetic changes. A result of karyotype analysis performed by a user is available (karyotype). |
|---|
| Comment from the depositor | |
|---|
| HPS0477 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0476, HPS0477, HPS0478 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0478 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0479 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal-Bulbar Muscular Atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0480 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0481 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0482 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal-Bulbar Muscular Atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0483 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0484 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0485 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0485, HPS0486, HPS0487 were derived from the same patient. Analysis of causal genetic changes. A result of karyotype analysis performed by a user is available (karyotype). |
|---|
| Comment from the depositor | |
|---|
| HPS0486 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0485, HPS0486, HPS0487 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0487 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0488 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Niemann-Pick disease, Type C variant biochemical phenotype). HPS0489 and HPS0490 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0489 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Niemann-Pick disease, Type C variant biochemical phenotype). HPS0488 and HPS0490 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0490 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Niemann-Pick disease, Type C variant biochemical phenotype). HPS0488 and HPS0489 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0491 |
|
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0492 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0493 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0507 |
| CiRA00160 |
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0508 |
| CiRA00161 |
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0510 |
|
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease (PD). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0512 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Fanconi anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS0515 |
|
| Comment | Disease specific iPS cell line derived from a patient : Chédiak-Higashi syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0516 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient :Chediak-Higashi syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0517 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Nakajo-Nishimura Syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0518 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Nakajo-Nishimura Syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0519 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Neutropenia, Kostmann syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0520 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Neutropenia, Kostmann syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0521 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Neutropenia, Kostmann syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0522 |
| CiRA00169 |
| Comment | Disease specific iPS cell line derived from a patient : Achondroplasia. HPS0523 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0523 |
| CiRA00170 |
| Comment | Disease specific iPS cell line derived from a patient : Achondroplasia. HPS0522 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0524 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Achondroplasia. |
|---|
| Comment from the depositor | |
|---|
| HPS0525 |
|
| Comment | Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0527 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0528 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0532 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0533 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0534 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0535 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0536 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0537 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0538 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0539 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0540 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0541 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS0542 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS0546 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)VI). |
|---|
| Comment from the depositor | |
|---|
| HPS0547 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)VI). |
|---|
| Comment from the depositor | |
|---|
| HPS0548 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)VI). |
|---|
| Comment from the depositor | |
|---|
| HPS0549 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)VI). |
|---|
| Comment from the depositor | |
|---|
| HPS0550 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)VI). |
|---|
| Comment from the depositor | |
|---|
| HPS0551 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)VI). |
|---|
| Comment from the depositor | |
|---|
| HPS0552 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. HPS0552, HPS0553, HPS0554, HPS0555, HPS0556, HPS0557 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0553 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. HPS0552, HPS0553, HPS0554, HPS0555, HPS0556, HPS0557 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0554 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. HPS0552, HPS0553, HPS0554, HPS0555, HPS0556, HPS0557 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0555 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0556 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0557 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0558 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0558, HPS0559, HPS0560, HPS0561, HPS0562, HPS0563 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0559 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0558, HPS0559, HPS0560, HPS0561, HPS0562, HPS0563 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0560 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0558, HPS0559, HPS0560, HPS0561, HPS0562, HPS0563 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0561 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0562 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0563 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0564 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0564, HPS0565, HPS0566, HPS0567, HPS0568, HPS0569 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0565 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0564, HPS0565, HPS0566, HPS0567, HPS0568, HPS0569 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0566 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0564, HPS0565, HPS0566, HPS0567, HPS0568, HPS0569 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0567 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0568 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0569 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0570 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0570, HPS0571, HPS0572, HPS0573, HPS0574, HPS0575 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0571 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0572 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0573 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0574 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0575 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0576 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0576, HPS0577, HPS0578, HPS0579, HPS0580, HPS0581 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0577 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0578 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0579 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0580 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0581 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0582 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0582, HPS0583, HPS0584, HPS0585, HPS0586, HPS0587 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0583 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0584 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0585 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0586 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0587 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0588 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0588, HPS0589, HPS0590, HPS0591, HPS0592, HPS0593 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0589 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0590 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0591 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0592 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0593 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0594 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0594, HPS0595, HPS0596, HPS0597, HPS0598, HPS0599 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0595 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0596 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0597 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0598 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0599 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0600 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0600, HPS0601, HPS0602, HPS0603, HPS0604, HPS0605 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0601 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0602 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0603 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0604 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0605 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0606 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0606, HPS0607, HPS0608, HPS0609, HPS0610, HPS0611 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0607 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0608 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0609 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0610 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0611 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0612 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0612, HPS0613, HPS0614, HPS0615, HPS0616, HPS0617 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0613 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0612, HPS0613, HPS0614, HPS0615, HPS0616, HPS0617 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0614 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0615 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0616 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0617 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0618 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0618, HPS0619, HPS0620, HPS0621, HPS0622, HPS0623 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0619 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0618, HPS0619, HPS0620, HPS0621, HPS0622, HPS0623 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0620 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0618, HPS0619, HPS0620, HPS0621, HPS0622, HPS0623 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0621 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0622 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0623 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0624 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0624, HPS0625, HPS0626, HPS0627, HPS0628, HPS0629 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0625 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0626 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0627 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0628 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0629 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0630 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0630, HPS0631, HPS0632, HPS0633, HPS0634, HPS0635 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0631 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0632 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0633 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0634 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0635 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0636 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0636, HPS0637, HPS0638, HPS0639, HPS0640, HPS0641 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0637 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0638 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0639 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0640 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0641 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0642 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0642, HPS0643, HPS0644, HPS0645, HPS0646, HPS0647 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0643 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0644 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0645 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0646 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0647 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0648 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0648, HPS0649, HPS0650, HPS0651, HPS0652, HPS0653 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0649 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0650 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0651 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0652 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0653 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0654 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal-Bulbar Muscular Atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0655 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0656 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0657 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0658 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0659 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal bulbar muscular atrophy (SBMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0660 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)). |
|---|
| Comment from the depositor | |
|---|
| HPS0661 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)). |
|---|
| Comment from the depositor | |
|---|
| HPS0662 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)). |
|---|
| Comment from the depositor | |
|---|
| HPS0663 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)). |
|---|
| Comment from the depositor | |
|---|
| HPS0664 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)). |
|---|
| Comment from the depositor | |
|---|
| HPS0665 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Mucopolysaccharidosis (MPS)). |
|---|
| Comment from the depositor | |
|---|
| HPS0666 |
|
| Comment | Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. HPS0666, HPS0667, HPS0668, HPS0669, HPS0670, HPS0671 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0667 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0668 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0669 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0670 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0671 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0672 |
|
| Comment | Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. HPS0672, HPS0673, HPS0674, HPS0675, HPS0676, HPS0677 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0673 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0674 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0675 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0676 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0677 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0678 |
|
| Comment | Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. HPS0678, HPS0679, HPS0680, HPS0681, HPS0682, HPS0683 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0679 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0680 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0681 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0682 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0683 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age-related Macular Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0684 |
|
| Comment | Human iPS cell line derived from a healthy individual. HPS0684, HPS0685, HPS0686, HPS0687 were derived from the same person. |
|---|
| Comment from the depositor | |
|---|
| HPS0685 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0686 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0687 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0688 |
|
| Comment | Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. HPS0688, HPS0689, HPS0690, HPS0691, HPS0692, HPS0693 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0689 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0690 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0691 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0692 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0693 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0694 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0695 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0696 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0697 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0698 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0699 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0700 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0701 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0702 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0703 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0704 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0705 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bietti crystalline retinopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0706 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0707 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0708 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0709 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0710 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0711 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS0712 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0713 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0714 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0715 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0716 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0717 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0718 |
|
| Comment | Human iPS cell line derived from a healthy individual. HPS0718, HPS0719, HPS0720, HPS0721, HPS0722, HPS0723 were derived from the same person. |
|---|
| Comment from the depositor | |
|---|
| HPS0719 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0720 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0721 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0722 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0723 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0724 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0724, HPS0725, HPS0726, HPS0727, HPS0728, HPS0729 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0725 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0726 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0727 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0728 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0729 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0730 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0730, HPS0731, HPS0732, HPS0733, HPS0734, HPS0735 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0731 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0732 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0733 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0734 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0735 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0736 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0736, HPS0737, HPS0738, HPS0739, HPS0740, HPS0741 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0737 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0738 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0739 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0740 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0741 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0742 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0742, HPS0743, HPS0744, HPS0745, HPS0746, HPS0747 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0743 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0744 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0745 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0746 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0747 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0748 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0748, HPS0749, HPS0750, HPS0751, HPS0752, HPS0753 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0749 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0750 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0751 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0752 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0753 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0754 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0754, HPS0755, HPS0756, HPS0757, HPS0758, HPS0759 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0755 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0756 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0757 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0758 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0759 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0760 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0760, HPS0761, HPS0762, HPS0763, HPS0764, HPS0765 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0761 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0762 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0763 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0764 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0765 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0766 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0766, HPS0767, HPS0768, HPS0769, HPS0770, HPS0771 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0767 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0768 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0769 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0770 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0771 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0772 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS0772, HPS0773, HPS0774, HPS0775 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0773 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS0772, HPS0773, HPS0774, HPS0775 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0774 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS0772, HPS0773, HPS0774, HPS0775 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0775 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS0776 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration. HPS0776, HPS0777, HPS0778, HPS0779, HPS0780, HPS0781 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0777 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0778 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0779 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0780 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0781 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0782 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0782, HPS0783, HPS0784, HPS0785, HPS0786, HPS0787 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0783 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0784 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0785 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0786 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0787 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0788 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0788, HPS0789, HPS0790, HPS0791, HPS0792, HPS0793 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0789 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0790 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0791 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0792 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0793 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0794 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0794, HPS0795, HPS0796, HPS0797, HPS0798, HPS0799 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0795 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0796 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0797 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0798 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0799 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0800 |
|
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease. HPS0800, HPS0801, HPS0802, HPS0803, HPS0804, HPS0805 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0801 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0802 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0803 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0804 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0805 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0806 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. HPS0806, HPS0807, HPS0808, HPS0809, HPS0810, HPS0811 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0807 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0808 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0809 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0810 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0811 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0812 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer's disease. HPS0060, HPS0812, HPS0813, HPS0814, HPS0815, HPS0816, HPS0817 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0813 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer's disease. HPS0060, HPS0812, HPS0813, HPS0814, HPS0815, HPS0816, HPS0817 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0814 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer's disease. HPS0060, HPS0812, HPS0813, HPS0814, HPS0815, HPS0816, HPS0817 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0815 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dementia of Alzheimer's type. |
|---|
| Comment from the depositor | |
|---|
| HPS0816 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dementia of Alzheimer's type. |
|---|
| Comment from the depositor | |
|---|
| HPS0817 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dementia of Alzheimer's type. |
|---|
| Comment from the depositor | |
|---|
| HPS0818 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS0818, HPS0819, HPS0820, HPS0821, HPS0822, HPS0823 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0819 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS0818, HPS0819, HPS0820, HPS0821, HPS0822, HPS0823 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0820 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS0818, HPS0819, HPS0820, HPS0821, HPS0822, HPS0823 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0821 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS0822 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS0823 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS0824 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0824, HPS0825, HPS0826, HPS0827, HPS0828, HPS0829 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0825 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0826 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0827 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0828 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0829 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0830 |
|
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0831 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0832 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0833 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0834 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0835 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0836 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0837 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0838 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0839 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0840 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0841 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0842 |
|
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease. HPS0842, HPS0843, HPS0844, HPS0845, HPS0846, HPS0847 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0843 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0844 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0845 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0846 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0847 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0848 |
|
| Comment | Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0849 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0850 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0851 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0852 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0853 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Parkinson's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0854 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer's disease. HPS0854, HPS0855, HPS0856, HPS0857, HPS0858, HPS0859 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0855 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer's disease. HPS0854, HPS0855, HPS0856, HPS0857, HPS0858, HPS0859 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0856 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer's disease. HPS0854, HPS0855, HPS0856, HPS0857, HPS0858, HPS0859 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0857 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0858 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0859 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alzheimer disease. |
|---|
| Comment from the depositor | |
|---|
| HPS0860 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0860, HPS0861, HPS0862, HPS0863, HPS0864, HPS0865 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0861 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0862 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0863 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0864 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0865 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0866 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0867 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0868 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0869 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0870 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0871 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0872 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0873 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0874 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0875 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0876 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0877 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS0878 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS) / Parkinsonism-dementia. HPS0878, HPS0879, HPS0880, HPS0881, HPS0882, HPS0883 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0879 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS) / Parkinsonism-dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0880 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS) / Parkinsonism-dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0881 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS) / Parkinsonism-dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0882 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS) / Parkinsonism-dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0883 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS) / Parkinsonism-dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS0884 |
|
| Comment | Human iPS cell line derived from a healthy individual. HPS0884, HPS0885, HPS0886, HPS0887, HPS0888, HPS0889 were derived from the same person. |
|---|
| Comment from the depositor | |
|---|
| HPS0885 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0886 |
|
| Comment | Human iPS cell line derived from a healthy individual. HPS0884, HPS0885, HPS0886, HPS0887, HPS0888, HPS0889 were derived from the same person. |
|---|
| Comment from the depositor | |
|---|
| HPS0887 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0888 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0889 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS0890 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0890, HPS0891, HPS0892, HPS0893, HPS0894, HPS0895 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0891 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0892 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0893 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0894 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0895 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0896 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0896, HPS0897, HPS0898, HPS0899, HPS0900, HPS0901 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0897 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0898 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0899 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0900 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0901 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0902 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0902, HPS0903, HPS0904, HPS0905, HPS0906, HPS0907 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0903 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0904 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0905 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0906 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0907 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0908 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0908, HPS0909, HPS0910, HPS0911, HPS0912, HPS0913 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0909 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0910 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0911 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0912 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0913 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0914 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0914, HPS0915, HPS0916, HPS0917, HPS0918, HPS0919 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0915 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0916 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0917 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0918 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0919 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0920 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0920, HPS0921, HPS0922, HPS0923, HPS0924, HPS0925 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0921 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0922 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0923 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0924 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0925 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0926 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0926, HPS0927, HPS0928, HPS0929, HPS0930, HPS0931 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS0927 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0928 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0929 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0930 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0931 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS0932 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA). HPS0932, HPS0933, HPS0934, HPS0935, HPS0936, HPS0937 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS0933 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0934 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0935 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0936 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0937 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA). |
|---|
| Comment from the depositor | |
|---|
| HPS0938 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. |
|---|
| Comment from the depositor | |
|---|
| HPS0939 |
|
| Comment | Disease specific iPS cell line derived from a patient : Achondroplasia. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0940 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Achondroplasia. |
|---|
| Comment from the depositor | |
|---|
| HPS0941 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Achondroplasia. |
|---|
| Comment from the depositor | |
|---|
| HPS0942 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0943 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0944 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0945 |
|
| Comment | Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0946 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0947 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0948 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0949 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0950 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0951 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0952 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta. |
|---|
| Comment from the depositor | |
|---|
| HPS0953 |
|
| Comment | Disease specific iPS cell line derived from a patient : Achondroplasia. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS0954 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Achondroplasia. |
|---|
| Comment from the depositor | |
|---|
| HPS0961 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0962 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0963 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0964 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0965 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0966 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0967 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0968 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0969 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0970 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0971 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0972 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0973 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0974 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0975 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0976 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0977 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0978 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0979 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0980 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0981 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0983 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0984 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0985 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0986 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0987 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0988 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0989 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0990 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS0991 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0992 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0993 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0994 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0995 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0996 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS0997 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1000 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (C). |
|---|
| Comment from the depositor | |
|---|
| HPS1001 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (C). |
|---|
| Comment from the depositor | |
|---|
| HPS1002 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (C). |
|---|
| Comment from the depositor | |
|---|
| HPS1003 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (C). |
|---|
| Comment from the depositor | |
|---|
| HPS1004 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (C). |
|---|
| Comment from the depositor | |
|---|
| HPS1005 |
| 1383D2 |
| Comment | Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1006 |
| 1383D6 |
| Comment | Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1007 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). |
|---|
| Comment from the depositor | |
|---|
| HPS1008 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). |
|---|
| Comment from the depositor | |
|---|
| HPS1009 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). |
|---|
| Comment from the depositor | |
|---|
| HPS1010 |
|
| Comment | Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. HPS0407 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1011 |
|
| Comment | Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1012 |
|
| Comment | Disease specific iPS cell line derived from a patient : Best disease. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1013 |
|
| Comment | Disease specific iPS cell line derived from a patient : Gelatinous drop-like corneal dystrophy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1014 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Reducing body myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1015 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Reducing body myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1016 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Reducing body myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1017 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bethlem myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1018 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bethlem myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1019 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bethlem myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1020 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myotubular myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1021 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myotubular myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1022 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myotubular myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1023 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Schwartz-Jampel syndrome (SJS). |
|---|
| Comment from the depositor | |
|---|
| HPS1024 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Schwartz-Jampel syndrome (SJS). |
|---|
| Comment from the depositor | |
|---|
| HPS1025 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Schwartz-Jampel syndrome (SJS). |
|---|
| Comment from the depositor | |
|---|
| HPS1026 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. |
|---|
| Comment from the depositor | |
|---|
| HPS1027 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. |
|---|
| Comment from the depositor | |
|---|
| HPS1028 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. |
|---|
| Comment from the depositor | |
|---|
| HPS1029 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1030 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1031 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Miyoshi Myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1032 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS1033 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS1034 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1035 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Analysis of causal genetic changes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1036 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Fahr disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1037 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1037, HPS1708, HPS1709 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1038 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1038, HPS1710, HPS1711 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1039 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia. HPS1039, HPS1712 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1040 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia. HPS1040, HPS1713, HPS1714 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1041 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Perry syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1042 |
|
| Comment | Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1043 |
|
| Comment | Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1044 |
|
| Comment | Human iPS cell line derived from a healthy individual. HPS0718, HPS0719, HPS0720, HPS0721, HPS0722, HPS0723, HPS1044, HPS1749 were derived from the same person. |
|---|
| Comment from the depositor | |
|---|
| HPS1045 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1046 |
|
| Comment | Disease specific iPS cell line derived from a healthy person. |
|---|
| Comment from the depositor | |
|---|
| HPS1047 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. HPS0552, HPS0553, HPS0554, HPS0555, HPS0556, HPS0557, HPS1047 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1048 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1049 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. HPS1049, HPS1718 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1050 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1051 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. HPS1051, HPS1703, HPS1704 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1052 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS1053 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1054 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1054, HPS3842, HPS3843 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1055 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1056 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1058 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1059 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1060 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1061 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular channelopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1062 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Periodic paralysis. |
|---|
| Comment from the depositor | |
|---|
| HPS1063 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Periodic paralysis. |
|---|
| Comment from the depositor | |
|---|
| HPS1064 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Periodic paralysis. |
|---|
| Comment from the depositor | |
|---|
| HPS1065 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Periodic paralysis. |
|---|
| Comment from the depositor | |
|---|
| HPS1066 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1067 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1068 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1069 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1070 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1071 |
|
| Comment | Disease specific iPS cell line derived from a patient : Leber Hereditary Optic Neuropathy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1072 |
|
| Comment | Disease specific iPS cell line derived from a patient : Age related Macular degeneration. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1073 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1074 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1075 |
|
| Comment | Disease specific iPS cell line derived from a patient : Retinitis pigmentosa. |
|---|
| Comment from the depositor | |
|---|
| HPS1076 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis. HPS1076, HPS1077 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of congenital insensitivity to pain with anhidrosis patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, c-MYC. |
|---|
| HPS1077 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis |
|---|
| Comment from the depositor | |
|---|
| HPS1078 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1079 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1080 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1081 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1082 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1083 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1084 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1085 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1086 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1087 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1088 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1089 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1090 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). The analysis performed by RIKEN BRC indicated a mutation, 1201C>T (p.R401W) in ABCD1 gene. HPS1090, HPS1091, HPS1092, HPS1093, HPS1094, HPS1095 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of adrenoleukodystrophy (ALD) patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, and c-MYC. |
|---|
| HPS1091 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). HPS1090, HPS1091, HPS1092, HPS1093, HPS1094, HPS1095 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of adrenoleukodystrophy (ALD) patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, and c-MYC. |
|---|
| HPS1092 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). HPS1090, HPS1091, HPS1092, HPS1093, HPS1094, HPS1095 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of adrenoleukodystrophy (ALD) patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, and c-MYC. |
|---|
| HPS1093 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1094 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1095 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1096 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). The analysis performed by RIKEN BRC indicated a mutation, 2010_2014delinsTAT (p.L670Ffs*63) in ABCD1 gene. HPS1096, HPS1097, HPS1098, HPS1099, HPS1100, HPS1101 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of adrenoleukodystrophy (ALD) patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, and c-MYC. |
|---|
| HPS1097 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). HPS1096, HPS1097, HPS1098, HPS1099, HPS1100, HPS1101 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of adrenoleukodystrophy (ALD) patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, and c-MYC. |
|---|
| HPS1098 |
|
| Comment | Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). HPS1096, HPS1097, HPS1098, HPS1099, HPS1100, HPS1101 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the skin fibroblast of adrenoleukodystrophy (ALD) patient using retrovirus vectors encoding OCT3/4, SOX2, KLF4, and c-MYC. |
|---|
| HPS1099 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1100 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1101 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Adrenoleukodystrophy (ALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1102 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1103 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1104 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1105 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1106 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1107 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1108 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1109 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1110 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1111 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1112 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1113 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1114 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1115 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1116 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1117 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1118 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1119 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rheumatoid Arthritis. |
|---|
| Comment from the depositor | |
|---|
| HPS1120 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of rheumatoid arthritis patient (HPS1114〜HPS1119). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblast of healthy of rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, sh-p53 and EBNA1. |
|---|
| HPS1121 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of rheumatoid arthritis patient (HPS1114〜HPS1119). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblast of healthy of rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, sh-p53 and EBNA1. |
|---|
| HPS1122 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of rheumatoid arthritis patient (HPS1114〜HPS1119). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblast of healthy of rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, sh-p53 and EBNA1. |
|---|
| HPS1123 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of rheumatoid arthritis patient (HPS1114〜HPS1119). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblast of healthy of rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, sh-p53 and EBNA1. |
|---|
| HPS1124 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of rheumatoid arthritis patient (HPS1114〜HPS1119). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblast of healthy of rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, sh-p53 and EBNA1. |
|---|
| HPS1125 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of rheumatoid arthritis patient (HPS1114〜HPS1119). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblast of healthy of rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, sh-p53 and EBNA1. |
|---|
| HPS1126 |
|
| Comment | Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. HPS1127, HPS1128, HPS1132, HPS1133 and HPS1134 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1127 |
|
| Comment | Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. HPS1126, HPS1128, HPS1132, HPS1133 and HPS1134 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1128 |
|
| Comment | Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. HPS1126, HPS1127, HPS1132, HPS1133 and HPS1134 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1129 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS1130 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS1131 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS1132 |
|
| Comment | Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. HPS1126, HPS1127, HPS1128, HPS1133 and HPS1134 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1133 |
|
| Comment | Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. HPS1126, HPS1127, HPS1128, HPS1132 and HPS1134 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1134 |
|
| Comment | Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. HPS1126, HPS1127, HPS1128, HPS1132 and HPS1133 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1135 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS1136 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS1137 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Diamond-Blackfan anemia. |
|---|
| Comment from the depositor | |
|---|
| HPS1138 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1139 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1140 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1141 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1142 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1143 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1144 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblas of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1145 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblas of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1146 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblas of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1147 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblas of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1148 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblas of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1149 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of Diamond-Blackfan anemia patient (HPS1126, HPS1127, HPS1128 〜HPS1131, HPS1132, HPS1133, HPS1134 〜HPS1137). |
|---|
| Comment from the depositor | Family control iPS cells. iPS cells were established from the skin fibroblas of healthy family of Diamond-Blackfan anemia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1150 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1151 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1152 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1153 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1154 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1155 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1156 |
|
| Comment | Disease specific iPS cell line derived from a patient : Rett syndrome. HPS1156, HPS1157, HPS1158, HPS1159, HPS1160, HPS1161 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Rett syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1157 |
|
| Comment | Disease specific iPS cell line derived from a patient : Rett syndrome. HPS1156, HPS1157, HPS1158, HPS1159, HPS1160, HPS1161 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Rett syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1158 |
|
| Comment | Disease specific iPS cell line derived from a patient : Rett syndrome. HPS1156, HPS1157, HPS1158, HPS1159, HPS1160, HPS1161 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Rett syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1159 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rett syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1160 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rett syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1161 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rett syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1162 |
|
| Comment | Currently not ready. Human iPS cell line derived from a healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1163 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1164 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1165 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1166 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1167 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1168 |
|
| Comment | Human iPS cell line derived from a healthy individual. HPS1168, HPS1169, HPS1170, HPS1171, HPS1172, HPS1173 were derived from the same person. |
|---|
| Comment from the depositor | Healty control iPS cells. iPS cells were established from the peripheral blood mononuclear cells of healthy donor using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1169 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1170 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1171 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1172 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1173 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1174 |
|
| Comment | Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). HPS1174, HPS1175, HPS1176, HPS1177, HPS1178, HPS1179 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Primary biliary cirrhosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1175 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1176 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1177 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1178 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1179 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1180 |
|
| Comment | Disease specific iPS cell line derived from a patient : IgA nephropathy. HPS1180, HPS1181, HPS1182, HPS1183, HPS1184, HPS1185 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of IgA nephropathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1181 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1182 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1183 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1184 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1185 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1186 |
|
| Comment | Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. HPS1186, HPS1187, HPS1188, HPS1189, HPS1190, HPS1191 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of refractory nephrotic syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1187 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1188 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1189 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1190 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1191 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1192 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, unclassified. |
|---|
| Comment from the depositor | |
|---|
| HPS1193 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, unclassified. |
|---|
| Comment from the depositor | |
|---|
| HPS1194 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, unclassified. |
|---|
| Comment from the depositor | |
|---|
| HPS1195 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, unclassified. |
|---|
| Comment from the depositor | |
|---|
| HPS1196 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, unclassified. |
|---|
| Comment from the depositor | |
|---|
| HPS1197 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, unclassified. |
|---|
| Comment from the depositor | |
|---|
| HPS1198 |
|
| Comment | Disease specific iPS cell line derived from a patient : Morphea with autoimmune hepatitis. HPS1198, HPS1199, HPS1200, HPS1201, HPS1202, HPS1203 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Morphea with autoimmune hepatitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1199 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Morphea with autoimmune hepatitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1200 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Morphea with autoimmune hepatitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1201 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Morphea with autoimmune hepatitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1202 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Morphea with autoimmune hepatitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1203 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Morphea with autoimmune hepatiti |
|---|
| Comment from the depositor | |
|---|
| HPS1204 |
|
| Comment | Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. HPS1204, HPS1205, HPS1206, HPS1207, HPS1208, HPS1209 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Langerhans cell histiocytosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1205 |
|
| Comment | Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. HPS1204, HPS1205, HPS1206, HPS1207, HPS1208, HPS1209 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Langerhans cell histiocytosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1206 |
|
| Comment | Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. HPS1204, HPS1205, HPS1206, HPS1207, HPS1208, HPS1209 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Langerhans cell histiocytosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1207 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1208 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1209 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1210 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1211 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1212 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1213 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1214 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1215 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1216 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS1216, HPS1217, HPS1218, HPS1219, HPS1220, HPS1221 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of systemic sclerosis (SSc) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1217 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1218 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1219 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1220 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1221 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1222 |
|
| Comment | Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). HPS1222, HPS1223, HPS1224, HPS1225, HPS1226, HPS1227 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of autoimmune hepatitis (AIH) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1223 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1224 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1225 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1226 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1227 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1228 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1229 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1230 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1231 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1232 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1233 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus vulgaris. |
|---|
| Comment from the depositor | |
|---|
| HPS1234 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1235 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1236 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1237 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1238 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1239 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1240 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS1240, HPS1241, HPS1242, HPS1243, HPS1244, HPS1245 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of systemic sclerosis (SSc) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1241 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1242 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1243 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1244 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1245 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1246 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1247 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1248 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1249 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1250 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1251 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1252 |
|
| Comment | Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. HPS1252, HPS1253, HPS1254, HPS1255, HPS1256, HPS1257 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Langerhans cell histiocytosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1253 |
|
| Comment | Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. HPS1252, HPS1253, HPS1254, HPS1255, HPS1256, HPS1257 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Langerhans cell histiocytosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1254 |
|
| Comment | Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. HPS1252, HPS1253, HPS1254, HPS1255, HPS1256, HPS1257 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Langerhans cell histiocytosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1255 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1256 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1257 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Langerhans cell histiocytosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1258 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS1258, HPS1259, HPS1260, HPS1261, HPS1262, HPS1263 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of systemic sclerosis (SSc) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1259 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1260 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1261 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1262 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1263 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1264 |
|
| Comment | Disease specific iPS cell line derived from a patient : Polycystic kidney disease, unknown genetic etiology. HPS1264, HPS1265, HPS1266, HPS1267, HPS1268, HPS1269 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of polycystic kidney disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1265 |
|
| Comment | Disease specific iPS cell line derived from a patient : Polycystic Kidney disease, unknown genetic etiology. HPS1264, HPS1265, HPS1266, HPS1267, HPS1268, HPS1269 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of polycystic Kidney disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1266 |
|
| Comment | Disease specific iPS cell line derived from a patient : Polycystic Kidney disease, unknown genetic etiology. HPS1264, HPS1265, HPS1266, HPS1267, HPS1268, HPS1269 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of polycystic Kidney disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1267 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polycystic Kidney disease, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1268 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polycystic Kidney disease, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1269 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polycystic Kidney disease, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1270 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1271 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1272 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1273 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1274 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1275 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hepatitis (AIH). |
|---|
| Comment from the depositor | |
|---|
| HPS1276 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1277 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1278 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1279 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1280 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1281 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1282 |
|
| Comment | Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, central diabetes insipidus (CDI). HPS1282, HPS1283, HPS1284, HPS1285, HPS1286, HPS1287 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of disorders of pituitary ADH secretion patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1283 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, central diabetes insipidus (CDI). |
|---|
| Comment from the depositor | |
|---|
| HPS1284 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, central diabetes insipidus (CDI). |
|---|
| Comment from the depositor | |
|---|
| HPS1285 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, central diabetes insipidus (CDI). |
|---|
| Comment from the depositor | |
|---|
| HPS1286 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, central diabetes insipidus (CDI). |
|---|
| Comment from the depositor | |
|---|
| HPS1287 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, central diabetes insipidus (CDI). |
|---|
| Comment from the depositor | |
|---|
| HPS1288 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mixed Connective-Tissue Disease (MCTD), anti U1-RNP antibody(+). HPS1288, HPS1289, HPS1290, HPS1291, HPS1292, HPS1293 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Mixed Connective-Tissue disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1289 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mixed Connective-Tissue Disease (MCTD), anti U1-RNP antibody(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1290 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mixed Connective-Tissue Disease (MCTD), anti U1-RNP antibody(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1291 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mixed Connective-Tissue Disease (MCTD), anti U1-RNP antibody(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1292 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mixed Connective-Tissue Disease (MCTD), anti U1-RNP antibody(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1293 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mixed Connective-Tissue Disease (MCTD), anti U1-RNP antibody(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1294 |
|
| Comment | Disease specific iPS cell line derived from a patient : Behcet's disease, complete type. HPS1294, HPS1295, HPS1296, HPS1297, HPS1298, HPS1299 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of behcet disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1295 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, complete type. |
|---|
| Comment from the depositor | |
|---|
| HPS1296 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, complete type. |
|---|
| Comment from the depositor | |
|---|
| HPS1297 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, complete type. |
|---|
| Comment from the depositor | |
|---|
| HPS1298 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, complete type. |
|---|
| Comment from the depositor | |
|---|
| HPS1299 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, complete type. |
|---|
| Comment from the depositor | |
|---|
| HPS1300 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, transection of the pituitary stalk. |
|---|
| Comment from the depositor | |
|---|
| HPS1301 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, transection of the pituitary stalk. |
|---|
| Comment from the depositor | |
|---|
| HPS1302 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, transection of the pituitary stalk. |
|---|
| Comment from the depositor | |
|---|
| HPS1303 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, transection of the pituitary stalk. |
|---|
| Comment from the depositor | |
|---|
| HPS1304 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, transection of the pituitary stalk. |
|---|
| Comment from the depositor | |
|---|
| HPS1305 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, transection of the pituitary stalk. |
|---|
| Comment from the depositor | |
|---|
| HPS1306 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN), MPO-ANCA(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1307 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN), MPO-ANCA(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1308 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN), MPO-ANCA(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1309 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN), MPO-ANCA(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1310 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN), MPO-ANCA(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1311 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN), MPO-ANCA(+). |
|---|
| Comment from the depositor | |
|---|
| HPS1312 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS1313 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS1314 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS1315 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS1316 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS1317 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS1318 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. HPS1319 and HPS1320 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1319 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. HPS1318 and HPS1320 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1320 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. HPS1318 and HPS1319 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1321 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. |
|---|
| Comment from the depositor | |
|---|
| HPS1322 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. |
|---|
| Comment from the depositor | |
|---|
| HPS1323 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. |
|---|
| Comment from the depositor | |
|---|
| HPS1324 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1325 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus foliaceus. |
|---|
| Comment from the depositor | |
|---|
| HPS1326 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus foliaceus. |
|---|
| Comment from the depositor | |
|---|
| HPS1327 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus foliaceus. |
|---|
| Comment from the depositor | |
|---|
| HPS1328 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus foliaceus. |
|---|
| Comment from the depositor | |
|---|
| HPS1329 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus foliaceus. |
|---|
| Comment from the depositor | |
|---|
| HPS1330 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigus, pemphigus foliaceus. |
|---|
| Comment from the depositor | |
|---|
| HPS1331 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita). HPS1331, HPS1332, HPS1333, HPS1334, HPS1335, HPS1336 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of pemphigoid (including epidermolysis bullosa acquisita) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1332 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita). |
|---|
| Comment from the depositor | |
|---|
| HPS1333 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita). |
|---|
| Comment from the depositor | |
|---|
| HPS1334 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita). |
|---|
| Comment from the depositor | |
|---|
| HPS1335 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita). |
|---|
| Comment from the depositor | |
|---|
| HPS1336 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita). |
|---|
| Comment from the depositor | |
|---|
| HPS1337 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. HPS1337, HPS1338, HPS1339, HPS1340, HPS1341, HPS1342 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1338 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. HPS1337, HPS1338, HPS1339, HPS1340, HPS1341, HPS1342 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1339 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. HPS1337, HPS1338, HPS1339, HPS1340, HPS1341, HPS1342 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1340 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1341 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1342 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1343 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-50 of DMD gene. HPS1343, HPS1344, HPS1345, HPS1346, HPS1347, HPS1348 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1344 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-50 of DMD gene. HPS1343, HPS1344, HPS1345, HPS1346, HPS1347, HPS1348 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1345 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-50 of DMD gene. HPS1343, HPS1344, HPS1345, HPS1346, HPS1347, HPS1348 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1346 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-50 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1347 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-50 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1348 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-50 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1349 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. HPS1349, HPS1350, HPS1351, HPS1352, HPS1353, HPS1354 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1350 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. HPS1349, HPS1350, HPS1351, HPS1352, HPS1353, HPS1354 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1351 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. HPS1349, HPS1350, HPS1351, HPS1352, HPS1353, HPS1354 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1352 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1353 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1354 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 47-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1355 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-52 of DMD gene. HPS1355, HPS1356, HPS1357, HPS1358, HPS1359, HPS1360 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1356 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-52 of DMD gene. HPS1355, HPS1356, HPS1357, HPS1358, HPS1359, HPS1360 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1357 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-52 of DMD gene. HPS1355, HPS1356, HPS1357, HPS1358, HPS1359, HPS1360 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1358 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1359 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1360 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, deletion of exons 49-52 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1361 |
|
| Comment | Disease specific iPS cell line derived from a patient : Primary immunodeficiency syndrome, common variable immunodeficiency. HPS1361, HPS1362, HPS1363, HPS1364, HPS1365, HPS1366 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of primary immunodeficiency syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1362 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary immunodeficiency syndrome, common variable immunodeficiency. |
|---|
| Comment from the depositor | |
|---|
| HPS1363 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary immunodeficiency syndrome, common variable immunodeficiency. |
|---|
| Comment from the depositor | |
|---|
| HPS1364 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary immunodeficiency syndrome, common variable immunodeficiency. |
|---|
| Comment from the depositor | |
|---|
| HPS1365 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary immunodeficiency syndrome, common variable immunodeficiency. |
|---|
| Comment from the depositor | |
|---|
| HPS1366 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary immunodeficiency syndrome, common variable immunodeficiency. |
|---|
| Comment from the depositor | |
|---|
| HPS1367 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, duplication of exons 3-7 of DMD gene. HPS1367, HPS1368, HPS1369, HPS1370, HPS1371, HPS1372 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1368 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, duplication of exons 3-7 of DMD gene. HPS1367, HPS1368, HPS1369, HPS1370, HPS1371, HPS1372 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1369 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, duplication of exons 3-7 of DMD gene. HPS1367, HPS1368, HPS1369, HPS1370, HPS1371, HPS1372 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of muscular dystrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1370 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, duplication of exons 3-7 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1371 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, duplication of exons 3-7 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1372 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, duplication of exons 3-7 of DMD gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1373 |
|
| Comment | Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, idiopathic pulmonary arterial hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1374 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, idiopathic pulmonary arterial hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1375 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, idiopathic pulmonary arterial hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1376 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, idiopathic pulmonary arterial hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1377 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, idiopathic pulmonary arterial hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1378 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, idiopathic pulmonary arterial hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1379 |
|
| Comment | Disease specific iPS cell line derived from a patient : Buerger's disease. HPS1379, HPS1380, HPS1381, HPS1382, HPS1383, HPS1384 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Buerger's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1380 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1381 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1382 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1383 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1384 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1385 |
|
| Comment | Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1386 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1387 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1388 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1389 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1390 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1391 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA), Spinal muscular atrophy type 2. HPS1391, HPS1392, HPS1393, HPS1394, HPS1395, HPS1396 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Spinal muscular atrophy (SMA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1392 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA), Spinal muscular atrophy type 2. HPS1391, HPS1392, HPS1393, HPS1394, HPS1395, HPS1396 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Spinal muscular atrophy (SMA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1393 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA), Spinal muscular atrophy type 2. HPS1391, HPS1392, HPS1393, HPS1394, HPS1395, HPS1396 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Spinal muscular atrophy (SMA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1394 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA), Spinal muscular atrophy type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS1395 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA), Spinal muscular atrophy type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS1396 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal muscular atrophy (SMA), Spinal muscular atrophy type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS1397 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. HPS1397, HPS1398, HPS1399, HPS1400, HPS1401, HPS1402 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ulcerative colitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1398 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. HPS1397, HPS1398, HPS1399, HPS1400, HPS1401, HPS1402 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ulcerative colitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1399 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. HPS1397, HPS1398, HPS1399, HPS1400, HPS1401, HPS1402 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ulcerative colitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1400 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1401 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1402 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1403 |
|
| Comment | Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS1404 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS1405 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS1406 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS1407 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS1408 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS1409 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS1409, HPS1410, HPS1411, HPS1412, HPS1413, HPS1414 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Systemic sclerosis (SSc) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1410 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1411 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1412 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1413 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1414 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS1421 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1421, HPS1422, HPS1423, HPS1424, HPS1425, HPS1426 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1422 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1421, HPS1422, HPS1423, HPS1424, HPS1425, HPS1426 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1423 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1421, HPS1422, HPS1423, HPS1424, HPS1425, HPS1426 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1424 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1421, HPS1422, HPS1423, HPS1424, HPS1425, HPS1426 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1425 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1421, HPS1422, HPS1423, HPS1424, HPS1425, HPS1426 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1426 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1421, HPS1422, HPS1423, HPS1424, HPS1425, HPS1426 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1427 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Cystinosis). HPS1427, HPS1428, HPS1429 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of cystinosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1428 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Cystinosis). HPS1427, HPS1428, HPS1429 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of cystinosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1429 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Cystinosis). HPS1427, HPS1428, HPS1429 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of cystinosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1430 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. HPS1430, HPS1431, HPS1432, HPS1433, HPS1434, HPS1435 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ulcerative colitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1431 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. HPS1430, HPS1431, HPS1432, HPS1433, HPS1434, HPS1435 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ulcerative colitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1432 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. HPS1430, HPS1431, HPS1432, HPS1433, HPS1434, HPS1435 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ulcerative colitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1433 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1434 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1435 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ulcerative colitis, total colitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1436 |
|
| Comment | Disease specific iPS cell line derived from a patient : Distal myopathy, DMRV / GNE myopathy. HPS1436, HPS1437, HPS1438, HPS1439, HPS1440, HPS1441 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of distal myopathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1437 |
|
| Comment | Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. HPS1436, HPS1437, HPS1438, HPS1439, HPS1440, HPS1441 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of distal myopathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1438 |
|
| Comment | Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. HPS1436, HPS1437, HPS1438, HPS1439, HPS1440, HPS1441 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of distal myopathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1439 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1440 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1441 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1442 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alexander disease, type 2 (GFAP mutation). HPS1442, HPS1443, HPS1444, HPS1445, HPS1446, HPS1447 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Alexander disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1443 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2 (GFAP mutation). |
|---|
| Comment from the depositor | |
|---|
| HPS1444 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2 (GFAP mutation). |
|---|
| Comment from the depositor | |
|---|
| HPS1445 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2 (GFAP mutation). |
|---|
| Comment from the depositor | |
|---|
| HPS1446 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2 (GFAP mutation). |
|---|
| Comment from the depositor | |
|---|
| HPS1447 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2 (GFAP mutation). |
|---|
| Comment from the depositor | |
|---|
| HPS1448 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-Hydroxylase deficiency / simple virilizing form. HPS1448, HPS1449, HPS1450, HPS1451, HPS1452, HPS1453 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Congenital Adrenal enzyme deficiency patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1449 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-Hydroxylase deficiency / simple virilizing form. |
|---|
| Comment from the depositor | |
|---|
| HPS1450 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-Hydroxylase deficiency / simple virilizing form. |
|---|
| Comment from the depositor | |
|---|
| HPS1451 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-Hydroxylase deficiency / simple virilizing form. |
|---|
| Comment from the depositor | |
|---|
| HPS1452 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-Hydroxylase deficiency / simple virilizing form. |
|---|
| Comment from the depositor | |
|---|
| HPS1453 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-Hydroxylase deficiency / simple virilizing form. |
|---|
| Comment from the depositor | |
|---|
| HPS1454 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, relapsing-remitting MS. HPS1454, HPS1455, HPS1456, HPS1457, HPS1458, HPS1459 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple sclerosis / neuromyelitis optica patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1455 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, relapsing-remitting MS. HPS1454, HPS1455, HPS1456, HPS1457, HPS1458, HPS1459 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple sclerosis / neuromyelitis optica patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1456 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, relapsing-remitting MS. |
|---|
| Comment from the depositor | |
|---|
| HPS1457 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, relapsing-remitting MS. |
|---|
| Comment from the depositor | |
|---|
| HPS1458 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, relapsing-remitting MS. |
|---|
| Comment from the depositor | |
|---|
| HPS1459 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, relapsing-remitting MS. |
|---|
| Comment from the depositor | |
|---|
| HPS1460 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dravet syndrome, heterozygous mutation of SCN1A. HPS1460, HPS1461, HPS1462, HPS1463, HPS1464, HPS1465 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Dravet syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1461 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dravet syndrome, heterozygous mutation of SCN1A. HPS1460, HPS1461, HPS1462, HPS1463, HPS1464, HPS1465 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Dravet syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1462 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dravet syndrome, heterozygous mutation of SCN1A. HPS1460, HPS1461, HPS1462, HPS1463, HPS1464, HPS1465 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Dravet syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1463 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dravet syndrome, heterozygous mutation of SCN1A. |
|---|
| Comment from the depositor | |
|---|
| HPS1464 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dravet syndrome, heterozygous mutation of SCN1A. |
|---|
| Comment from the depositor | |
|---|
| HPS1465 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dravet syndrome, heterozygous mutation of SCN1A. |
|---|
| Comment from the depositor | |
|---|
| HPS1466 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1467 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1468 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1469 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1470 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1471 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1472 |
|
| Comment | Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1473 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1474 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1475 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1476 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1477 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1478 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Hunter syndorome, recombination of IDS preudogene). HPS1478, HPS1479, HPS1480, HPS1481, HPS1482, HPS1483 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Hunter syndorome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1479 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Hunter syndorome, recombination of IDS preudogene). HPS1478, HPS1479, HPS1480, HPS1481, HPS1482, HPS1483 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Hunter syndorome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1480 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Hunter syndorome, recombination of IDS preudogene). HPS1478, HPS1479, HPS1480, HPS1481, HPS1482, HPS1483 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Hunter syndorome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1481 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Hunter syndorome, recombination of IDS preudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1482 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Hunter syndorome, recombination of IDS preudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1483 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Hunter syndorome, recombination of IDS preudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1484 |
|
| Comment | Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. HPS1484, HPS1485, HPS1486, HPS1487, HPS1488, HPS1489 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1485 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1486 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1487 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1488 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1489 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1490 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1491 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1492 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1493 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1494 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1495 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary biliary cirrhosis (PBC). |
|---|
| Comment from the depositor | |
|---|
| HPS1496 |
|
| Comment | Disease specific iPS cell line derived from a patient : Sarcoidosis. HPS1496, HPS1497, HPS1498, HPS1499, HPS1500, HPS1501 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of sarcoidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1497 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1498 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1499 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1500 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1501 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1502 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, sporadic LAM. HPS1502, HPS1503, HPS1504, HPS1505, HPS1506, HPS1507 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of lymphangioleiomyomatosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1503 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, sporadic LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS1504 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, sporadic LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS1505 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, sporadic LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS1506 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, sporadic LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS1507 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, sporadic LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS1508 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crohn's disease, ileal type. HPS1508, HPS1509, HPS1510, HPS1511, HPS1512, HPS1513 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crohn's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1509 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crohn's disease, ileal type. HPS1508, HPS1509, HPS1510, HPS1511, HPS1512, HPS1513 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crohn's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1510 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crohn's disease, ileal type. HPS1508, HPS1509, HPS1510, HPS1511, HPS1512, HPS1513 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crohn's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1511 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crohn's disease, ileal type. |
|---|
| Comment from the depositor | |
|---|
| HPS1512 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crohn's disease, ileal type. |
|---|
| Comment from the depositor | |
|---|
| HPS1513 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crohn's disease, ileal type. |
|---|
| Comment from the depositor | |
|---|
| HPS1514 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). HPS1514, HPS1515, HPS1516, HPS1517, HPS1518, HPS1519 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of epilepsy with myoclonic absence (EMA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1515 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS1516 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS1517 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS1518 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS1519 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS1520 |
|
| Comment | Disease specific iPS cell line derived from a patient : IgA nephropathy. HPS1520, HPS1521, HPS1522, HPS1523, HPS1524, HPS1525 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of IgA nephropathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1521 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1522 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1523 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1524 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1525 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1526 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, secondary progressive multiple sclerosis. HPS1526, HPS1527, HPS1528, HPS1529, HPS1530, HPS1531 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple sclerosis / neuromyelitis optica patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1527 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, secondary progressive multiple sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1528 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, secondary progressive multiple sclerosis. HPS1526, HPS1527, HPS1528, HPS1529, HPS1530, HPS1531 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple sclerosis / neuromyelitis optica patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1529 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, secondary progressive multiple sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1530 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, secondary progressive multiple sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1531 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple sclerosis (MS) / Neuromyelitis optica, secondary progressive multiple sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1532 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). HPS1532, HPS1533, HPS1534, HPS1535, HPS1536, HPS1537 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of GM1-gangliosidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1533 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). HPS1532, HPS1533, HPS1534, HPS1535, HPS1536, HPS1537 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of GM1-gangliosidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1534 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). HPS1532, HPS1533, HPS1534, HPS1535, HPS1536, HPS1537 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of GM1-gangliosidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1535 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). |
|---|
| Comment from the depositor | |
|---|
| HPS1536 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). |
|---|
| Comment from the depositor | |
|---|
| HPS1537 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). |
|---|
| Comment from the depositor | |
|---|
| HPS1538 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1539 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1540 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1541 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1542 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1543 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS1544 |
|
| Comment | Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN), motor dominant. HPS1544, HPS1545, HPS1546, HPS1547, HPS1548, HPS1549 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1545 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN), motor dominant. |
|---|
| Comment from the depositor | |
|---|
| HPS1546 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN), motor dominant. |
|---|
| Comment from the depositor | |
|---|
| HPS1547 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN), motor dominant. |
|---|
| Comment from the depositor | |
|---|
| HPS1548 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN), motor dominant. |
|---|
| Comment from the depositor | |
|---|
| HPS1549 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP)/multifocal motor neuropathy (MMN), motor dominant. |
|---|
| Comment from the depositor | |
|---|
| HPS1550 |
|
| Comment | Disease specific iPS cell line derived from a patient : Smith-Magenis syndrome, chromosome 17p partial deletion. HPS1550, HPS1551, HPS1552, HPS1553, HPS1554, HPS1555 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Smith-Magenis syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1551 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Smith-Magenis syndrome, chromosome 17p partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1552 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Smith-Magenis syndrome, chromosome 17p partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1553 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Smith-Magenis syndrome, chromosome 17p partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1554 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Smith-Magenis syndrome, chromosome 17p partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1555 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Smith-Magenis syndrome, chromosome 17p partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1556 |
|
| Comment | Disease specific iPS cell line derived from a patient : Sotos Syndrome, chromosome 5q partial deletion. HPS1556, HPS1557, HPS1558, HPS1559, HPS1560, HPS1561 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Sotos Syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1557 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sotos Syndrome, chromosome 5q partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1558 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sotos Syndrome, chromosome 5q partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1559 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sotos Syndrome, chromosome 5q partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1560 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sotos Syndrome, chromosome 5q partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1561 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sotos Syndrome, chromosome 5q partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1562 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of growth hormone, pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1563 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of growth hormone, pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1564 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of growth hormone, pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1565 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of growth hormone, pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1566 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of growth hormone, pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1567 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of growth hormone, pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1568 |
|
| Comment | Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1569 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1570 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1571 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1572 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1573 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1574 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1575 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1576 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1577 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1578 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : IgA nephropathy |
|---|
| Comment from the depositor | |
|---|
| HPS1579 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA), regional type. |
|---|
| Comment from the depositor | |
|---|
| HPS1580 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA), regional type. |
|---|
| Comment from the depositor | |
|---|
| HPS1581 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA), regional type. |
|---|
| Comment from the depositor | |
|---|
| HPS1582 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA), regional type. |
|---|
| Comment from the depositor | |
|---|
| HPS1583 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA), regional type. |
|---|
| Comment from the depositor | |
|---|
| HPS1584 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA), regional type. |
|---|
| Comment from the depositor | |
|---|
| HPS1585 |
|
| Comment | Disease specific iPS cell line derived from a patient : Rasmussen encephalitis. HPS1585, HPS1586, HPS1587, HPS1588, HPS1589, HPS1590 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of rasmussen encephalitis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1586 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1587 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1588 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1589 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1590 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1591 |
|
| Comment | Disease specific iPS cell line derived from a patient : Focal cortical dysplasia (FCD). HPS1591, HPS1592, HPS1593, HPS1594, HPS1595, HPS1596 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of focal cortical dysplasia (FCD) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1592 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Focal cortical dysplasia (FCD). |
|---|
| Comment from the depositor | |
|---|
| HPS1593 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Focal cortical dysplasia (FCD). |
|---|
| Comment from the depositor | |
|---|
| HPS1594 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Focal cortical dysplasia (FCD). |
|---|
| Comment from the depositor | |
|---|
| HPS1595 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Focal cortical dysplasia (FCD). |
|---|
| Comment from the depositor | |
|---|
| HPS1596 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Focal cortical dysplasia (FCD). |
|---|
| Comment from the depositor | |
|---|
| HPS1597 |
|
| Comment | Disease specific iPS cell line derived from a patient : Angelman syndrome, chromosome 15 partial deletion. HPS1597, HPS1598, HPS1599, HPS1600, HPS1601, HPS1602 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Angelman syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1598 |
|
| Comment | Disease specific iPS cell line derived from a patient : Angelman syndrome, chromosome 15 partial deletion. HPS1597, HPS1598, HPS1599, HPS1600, HPS1601, HPS1602 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Angelman syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1599 |
|
| Comment | Disease specific iPS cell line derived from a patient : Angelman syndrome, chromosome 15 partial deletion. HPS1597, HPS1598, HPS1599, HPS1600, HPS1601, HPS1602 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Angelman syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1600 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Angelman syndrome, chromosome 15 partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1601 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Angelman syndrome, chromosome 15 partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1602 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Angelman syndrome, chromosome 15 partial deletion. |
|---|
| Comment from the depositor | |
|---|
| HPS1603 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS). HPS1603, HPS1604, HPS1605, HPS1606, HPS1607, HPS1608 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Lennox-Gastaut syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1604 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS). HPS1603, HPS1604, HPS1605, HPS1606, HPS1607, HPS1608 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Lennox-Gastaut syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1605 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS). HPS1603, HPS1604, HPS1605, HPS1606, HPS1607, HPS1608 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Lennox-Gastaut syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1606 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS). |
|---|
| Comment from the depositor | |
|---|
| HPS1607 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS). |
|---|
| Comment from the depositor | |
|---|
| HPS1608 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS). |
|---|
| Comment from the depositor | |
|---|
| HPS1609 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mesial temporal lobe epilepsy with hippocampal sclerosis. HPS1609, HPS1610, HPS1611, HPS1612, HPS1613, HPS1614 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of mesial temporal lobe epilepsy with hippocampal sclerosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1610 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mesial temporal lobe epilepsy with hippocampal sclerosis. HPS1609, HPS1610, HPS1611, HPS1612, HPS1613, HPS1614 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of mesial temporal lobe epilepsy with hippocampal sclerosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1611 |
|
| Comment | Disease specific iPS cell line derived from a patient : Mesial temporal lobe epilepsy with hippocampal sclerosis. HPS1609, HPS1610, HPS1611, HPS1612, HPS1613, HPS1614 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of mesial temporal lobe epilepsy with hippocampal sclerosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1612 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mesial temporal lobe epilepsy with hippocampal sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1613 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mesial temporal lobe epilepsy with hippocampal sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1614 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mesial temporal lobe epilepsy with hippocampal sclerosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1615 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neuronal migration disorder, schizencephaly. HPS1615, HPS1616, HPS1617, HPS1618, HPS1619, HPS1620 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of neuronal migration disorder patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1616 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neuronal migration disorder, schizencephaly. HPS1615, HPS1616, HPS1617, HPS1618, HPS1619, HPS1620 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of neuronal migration disorder patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1617 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neuronal migration disorder, schizencephaly. HPS1615, HPS1616, HPS1617, HPS1618, HPS1619, HPS1620 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of neuronal migration disorder patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1618 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, schizencephaly. |
|---|
| Comment from the depositor | |
|---|
| HPS1619 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, schizencephaly. |
|---|
| Comment from the depositor | |
|---|
| HPS1620 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, schizencephaly. |
|---|
| Comment from the depositor | |
|---|
| HPS1621 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome. HPS1621, HPS1622, HPS1623, HPS1624, HPS1625, HPS1626 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crow-Fukase syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1622 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome. HPS1621, HPS1622, HPS1623, HPS1624, HPS1625, HPS1626 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crow-Fukase syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1623 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1624 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1625 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1627 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. The analysis performed by RIKEN BRC indicated hemizygous deletion of 18,917,031_21,798,907 in 22q11.21 region (detected by CGH array). HPS1627, HPS1628, HPS1629, HPS1630, HPS1631 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1628 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS1627, HPS1628, HPS1629, HPS1630, HPS1631 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1629 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS1627, HPS1628, HPS1629, HPS1630, HPS1631 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1630 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS1627, HPS1628, HPS1629, HPS1630, HPS1631 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1631 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS1627, HPS1628, HPS1629, HPS1630, HPS1631 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1632 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, mutation of pseudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1633 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, mutation of pseudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1634 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, mutation of pseudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1635 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, mutation of pseudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1636 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, mutation of pseudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1637 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, mutation of pseudogene). |
|---|
| Comment from the depositor | |
|---|
| HPS1638 |
|
| Comment | Disease specific iPS cell line derived from a patient : Subacute sclerosing panencephalitis (SSPE). HPS1638, HPS1639, HPS1640, HPS1641, HPS1642, HPS1643 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of subacute sclerosing panencephalitis (SSPE) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1639 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Subacute sclerosing panencephalitis (SSPE). |
|---|
| Comment from the depositor | |
|---|
| HPS1640 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Subacute sclerosing panencephalitis (SSPE). |
|---|
| Comment from the depositor | |
|---|
| HPS1641 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Subacute sclerosing panencephalitis (SSPE). |
|---|
| Comment from the depositor | |
|---|
| HPS1642 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Subacute sclerosing panencephalitis (SSPE). |
|---|
| Comment from the depositor | |
|---|
| HPS1643 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Subacute sclerosing panencephalitis (SSPE). |
|---|
| Comment from the depositor | |
|---|
| HPS1644 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. HPS1644, HPS1645, HPS1646, HPS1647, HPS1648, HPS1649 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of epilepsy with continuous spikes and waves during slow sleep patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1645 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1646 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1647 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1648 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1649 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1650 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehelers-Danlos syndrome, vascular type. HPS1650, HPS1651, HPS1652, HPS1653, HPS1654 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ehelers-Danlos syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1651 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehelers-Danlos syndrome, vascular type. HPS1650, HPS1651, HPS1652, HPS1653, HPS1654 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ehelers-Danlos syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1652 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehelers-Danlos syndrome, vascular type. HPS1650, HPS1651, HPS1652, HPS1653, HPS1654 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ehelers-Danlos syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1653 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ehelers-Danlos syndrome, vascular type. |
|---|
| Comment from the depositor | |
|---|
| HPS1654 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ehelers-Danlos syndrome, vascular type. |
|---|
| Comment from the depositor | |
|---|
| HPS1655 |
|
| Comment | Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. HPS1655, HPS1656, HPS1657, HPS1658, HPS1659, HPS1660 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of PCDH19 epilepsy disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1656 |
|
| Comment | Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. HPS1655, HPS1656, HPS1657, HPS1658, HPS1659, HPS1660 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of PCDH19 epilepsy disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1657 |
|
| Comment | Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. HPS1655, HPS1656, HPS1657, HPS1658, HPS1659, HPS1660 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of PCDH19 epilepsy disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1658 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. |
|---|
| Comment from the depositor | |
|---|
| HPS1659 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. |
|---|
| Comment from the depositor | |
|---|
| HPS1660 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. |
|---|
| Comment from the depositor | |
|---|
| HPS1661 |
|
| Comment | Disease specific iPS cell line derived from a patient : Sturge-Weber syndrome, unknown genetic etiology. HPS1661, HPS1662, HPS1663, HPS1664, HPS1665, HPS1666 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Sturge-Weber syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1662 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sturge-Weber syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1663 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sturge-Weber syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1664 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sturge-Weber syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1665 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sturge-Weber syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1666 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sturge-Weber syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS1667 |
|
| Comment | Disease specific iPS cell line derived from a patient : Moyamoya disease, bilateral type. HPS1667, HPS1668, HPS1669, HPS1670, HPS1671, HPS1672 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of moyamoya disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1668 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease,bilateral type. |
|---|
| Comment from the depositor | |
|---|
| HPS1669 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease,bilateral type. |
|---|
| Comment from the depositor | |
|---|
| HPS1670 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease,bilateral type. |
|---|
| Comment from the depositor | |
|---|
| HPS1671 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease,bilateral type. |
|---|
| Comment from the depositor | |
|---|
| HPS1672 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease,bilateral type. |
|---|
| Comment from the depositor | |
|---|
| HPS1673 |
|
| Comment | Disease specific iPS cell line derived from a patient : Resistance to thyroid hormone, mutation in TR beta gene. HPS1673, HPS1674, HPS1675, HPS1676, HPS1677, HPS1678 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of resistance to thyroid hormone patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1674 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Resistance to Thyroid Hormone, mutation in TR beta gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1675 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Resistance to Thyroid Hormone, mutation in TR beta gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1676 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Resistance to Thyroid Hormone, mutation in TR beta gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1677 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Resistance to Thyroid Hormone, mutation in TR beta gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1678 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Resistance to Thyroid Hormone, mutation in TR beta gene. |
|---|
| Comment from the depositor | |
|---|
| HPS1679 |
|
| Comment | Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1680 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1681 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1682 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1683 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1684 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS1685 |
|
| Comment | Disease specific iPS cell line derived from a patient : 5p-syndrome. HPS1685, HPS1686, HPS1687, HPS1688, HPS1689, HPS1690 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 5p-syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1686 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1687 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1688 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1689 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1690 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1691 |
|
| Comment | Disease specific iPS cell line derived from a patient : Malignant rheumatoid arthritis (MRA). HPS1691, HPS1692, HPS1693, HPS1694, HPS1695, HPS1696 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of malignant rheumatoid arthritis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1692 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Malignant rheumatoid arthritis (MRA). |
|---|
| Comment from the depositor | |
|---|
| HPS1693 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Malignant rheumatoid arthritis (MRA). |
|---|
| Comment from the depositor | |
|---|
| HPS1694 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Malignant rheumatoid arthritis (MRA). |
|---|
| Comment from the depositor | |
|---|
| HPS1695 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Malignant rheumatoid arthritis (MRA). |
|---|
| Comment from the depositor | |
|---|
| HPS1696 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Malignant rheumatoid arthritis (MRA). |
|---|
| Comment from the depositor | |
|---|
| HPS1703 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS1704 |
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy. HPS1051, HPS1703, HPS1704 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1705 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1036, HPS1705 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1706 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1706, HPS1707 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1707 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1706, HPS1707 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1708 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1037, HPS1708, HPS1709 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1709 |
|
| Comment | Disease specific iPS cell line derived from a patient : Fahr disease. HPS1037, HPS1708, HPS1709 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1710 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Fahr disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1711 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Fahr disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1712 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hereditary dystonia. |
|---|
| Comment from the depositor | |
|---|
| HPS1713 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia. HPS1040, HPS1713, HPS1714 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1714 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hereditary dystonia. |
|---|
| Comment from the depositor | |
|---|
| HPS1715 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Perry syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1716 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Perry syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1717 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1718 |
|
| Comment | Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. HPS1049, HPS1718 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1719 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1720 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1721 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS0249, HPS1721, HPS1722 were derived from the same patient. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1722 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1723 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1724 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1725 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1726 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1727 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS1728 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy. HPS1728, HPS1729, HPS1730 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1729 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy. HPS1728, HPS1729, HPS1730 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1730 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy. HPS1728, HPS1729, HPS1730 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1731 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy. |
|---|
| Comment from the depositor | |
|---|
| HPS1732 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy. |
|---|
| Comment from the depositor | |
|---|
| HPS1733 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy. |
|---|
| Comment from the depositor | |
|---|
| HPS1745 |
| CiRA00003 |
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS1747 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1747 |
| CiRA00002 |
| Comment | Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS1745 was derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1748 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1749 |
|
| Comment | Currently not ready. Human iPS cell line derived from healthy individual. |
|---|
| Comment from the depositor | |
|---|
| HPS1750 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (A). |
|---|
| Comment from the depositor | |
|---|
| HPS1751 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum (C). |
|---|
| Comment from the depositor | |
|---|
| HPS1752 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic lupus erythematosus (SLE). |
|---|
| Comment from the depositor | |
|---|
| HPS1753 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic lupus erythematosus (SLE). |
|---|
| Comment from the depositor | |
|---|
| HPS1754 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic lupus erythematosus (SLE). |
|---|
| Comment from the depositor | |
|---|
| HPS1755 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic lupus erythematosus (SLE). |
|---|
| Comment from the depositor | |
|---|
| HPS1756 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age related Macular degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS1757 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age related Macular degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS1758 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age related Macular degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS1759 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Age related Macular degeneration. |
|---|
| Comment from the depositor | |
|---|
| HPS1760 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Best disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1761 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Best disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1762 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Best disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1763 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS1764 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS1765 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS1766 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1767 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1768 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1769 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1770 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1771 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1772 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1773 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1774 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1775 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1776 |
|
| Comment | Disease specific iPS cell line derived from a patient : Leber Hereditary Optic Neuropathy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1777 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sjogren's syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1788 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polymyositis (PM) |
|---|
| Comment from the depositor | |
|---|
| HPS1789 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polymyositis (PM) |
|---|
| Comment from the depositor | |
|---|
| HPS1790 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polymyositis (PM) |
|---|
| Comment from the depositor | |
|---|
| HPS1791 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polymyositis (PM) |
|---|
| Comment from the depositor | |
|---|
| HPS1792 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1793 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1794 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1795 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1796 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1797 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1798 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : RAS-associated autoimmune leukoproliferative disorder (RALD). |
|---|
| Comment from the depositor | |
|---|
| HPS1813 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Fulminant hepatitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1814 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1815 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Charcot-Marie-Tooth disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1816 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia. HPS1816, HPS1817 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS1817 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hereditary dystonia. |
|---|
| Comment from the depositor | |
|---|
| HPS1818 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1819 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1820 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1821 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1822 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1823 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1824 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1825 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1826 |
|
| Comment | Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). HPS1826, HPS1827 were derived from the same patient.Analysis of causal genetic changes. |
|---|
| Comment from the depositor | Amyotrophic lateral sclerosis, episomal vector (Oct3/4, mp53DDD, Sox2, KLF4, L-MYC, LIN28, EBNA1) |
|---|
| HPS1827 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1828 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1829 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1830 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1831 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1832 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1833 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1834 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1835 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1837 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Wiskott-Aldrich syndrome (WAS). |
|---|
| Comment from the depositor | |
|---|
| HPS1838 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Wiskott-Aldrich syndrome (WAS). |
|---|
| Comment from the depositor | |
|---|
| HPS1839 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Wiskott-Aldrich syndrome (WAS). |
|---|
| Comment from the depositor | |
|---|
| HPS1840 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Wiskott-Aldrich syndrome (WAS). |
|---|
| Comment from the depositor | |
|---|
| HPS1841 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polymyositis (PM) |
|---|
| Comment from the depositor | |
|---|
| HPS1842 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polymyositis (PM) |
|---|
| Comment from the depositor | |
|---|
| HPS1845 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1846 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1847 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bethlem myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1848 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Bethlem myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS1849 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ullrich congenital muscular dystrophy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | Ullrich congenital muscular dystrophy disease-specific iPS cell line. Established from fibroblast of patient transfected with episomal vector bearing Yamanaka 4-factors. |
|---|
| HPS1850 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1851 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1852 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1853 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mitochondrial disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1854 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Mitochondrial disease. |
|---|
| Comment from the depositor | |
|---|
| HPS1855 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital myasthenic syndromes. |
|---|
| Comment from the depositor | |
|---|
| HPS1887 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA6). Analysis of causal genetic changes.Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA6). |
|---|
| HPS1888 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA6). Analysis of causal genetic changes.Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA6). |
|---|
| HPS1889 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA6). Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA6). |
|---|
| HPS1890 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1891 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). |
|---|
| Comment from the depositor | |
|---|
| HPS1892 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1893 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1894 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1895 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1896 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1897 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA42). |
|---|
| Comment from the depositor | |
|---|
| HPS1898 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA31). Analysis of causal genetic changes. |
|---|
| Comment from the depositor | |
|---|
| HPS1899 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA31). HPS1898, HPS1899 were derived from the same patient. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | Disease specific iPS cell line derived from a patient : Spinocerebellar degeneration (SCA31). |
|---|
| HPS1900 |
|
| Comment | Disease specific iPS cell line derived from a patient : Leber Hereditary Optic Neuropathy. Cryopreserved by vitrification method. |
|---|
| Comment from the depositor | |
|---|
| HPS1901 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1902 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypopituitarism. |
|---|
| Comment from the depositor | |
|---|
| HPS1903 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Gelatinous drop-like corneal dystrophy. |
|---|
| Comment from the depositor | |
|---|
| HPS1904 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Familial central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS1905 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myelodysplastic syndromes |
|---|
| Comment from the depositor | |
|---|
| HPS1906 |
|
| Comment | Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD), Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1907 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1908 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1909 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1910 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1911 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Frontotemporal lobar degeneration (FTLD),Semantic Dementia. |
|---|
| Comment from the depositor | |
|---|
| HPS1912 |
|
| Comment | Disease specific iPS cell line derived from a patient : 1p36 deletion syndrome. HPS1912, HPS1913, HPS1914, HPS1915, HPS1916, HPS1917 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 1p36 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1913 |
|
| Comment | Disease specific iPS cell line derived from a patient : 1p36 deletion syndrome. HPS1912, HPS1913, HPS1914, HPS1915, HPS1916, HPS1917 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 1p36 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1914 |
|
| Comment | Disease specific iPS cell line derived from a patient : 1p36 deletion syndrome. HPS1912, HPS1913, HPS1914, HPS1915, HPS1916, HPS1917 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 1p36 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1915 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 1p36 deletion syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1916 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 1p36 deletion syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1917 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 1p36 deletion syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS1918 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Allergic granulomatous angiitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1919 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Allergic granulomatous angiitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1920 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Allergic granulomatous angiitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1921 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Allergic granulomatous angiitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1922 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Allergic granulomatous angiitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1923 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Allergic granulomatous angiitis. |
|---|
| Comment from the depositor | |
|---|
| HPS1924 |
|
| Comment | Disease specific iPS cell line derived from a patient : Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). HPS1924, HPS1925, HPS1926, HPS1927, HPS1928, HPS1929 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1925 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). |
|---|
| Comment from the depositor | |
|---|
| HPS1926 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). |
|---|
| Comment from the depositor | |
|---|
| HPS1927 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). |
|---|
| Comment from the depositor | |
|---|
| HPS1928 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). |
|---|
| Comment from the depositor | |
|---|
| HPS1929 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). |
|---|
| Comment from the depositor | |
|---|
| HPS1930 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic-astatic seizures. HPS1930, HPS1931, HPS1932, HPS1933, HPS1934, HPS1935 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of epilepsy with myoclonic-astatic seizures patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1931 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic-astatic seizures. |
|---|
| Comment from the depositor | |
|---|
| HPS1932 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic-astatic seizures. |
|---|
| Comment from the depositor | |
|---|
| HPS1933 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic-astatic seizures. |
|---|
| Comment from the depositor | |
|---|
| HPS1934 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic-astatic seizures. |
|---|
| Comment from the depositor | |
|---|
| HPS1935 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic-astatic seizures. |
|---|
| Comment from the depositor | |
|---|
| HPS1936 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Galactosialidosis, adult type). HPS1936, HPS1937, HPS1938, HPS1939, HPS1940, HPS1941 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of galactosialidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1937 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Galactosialidosis, adult type). HPS1936, HPS1937, HPS1938, HPS1939, HPS1940, HPS1941 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of galactosialidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1938 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Galactosialidosis, adult type). HPS1936, HPS1937, HPS1938, HPS1939, HPS1940, HPS1941 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of galactosialidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1939 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Galactosialidosis, adult type). |
|---|
| Comment from the depositor | |
|---|
| HPS1940 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Galactosialidosis, adult type). |
|---|
| Comment from the depositor | |
|---|
| HPS1941 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Galactosialidosis, adult type). |
|---|
| Comment from the depositor | |
|---|
| HPS1942 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia, Genetic dystonia, DYT11/mutation in SGCE. HPS1942, HPS1943, HPS1944, HPS1945, HPS1946, HPS1947 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of genetic dystonia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1943 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia, Genetic dystonia, DYT11/mutation in SGCE. HPS1942, HPS1943, HPS1944, HPS1945, HPS1946, HPS1947 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of genetic dystonia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1944 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hereditary dystonia, Genetic dystonia, DYT11/mutation in SGCE. HPS1942, HPS1943, HPS1944, HPS1945, HPS1946, HPS1947 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of genetic dystonia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1945 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hereditary dystonia. |
|---|
| Comment from the depositor | |
|---|
| HPS1946 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hereditary dystonia. |
|---|
| Comment from the depositor | |
|---|
| HPS1947 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hereditary dystonia. |
|---|
| Comment from the depositor | |
|---|
| HPS1948 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ossification of the yellow ligament (OYL). HPS1948, HPS1949, HPS1950, HPS1951, HPS1952, HPS1953 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of ossification of the yellow ligament (OYL) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1949 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ossification of the yellow ligament (OYL). |
|---|
| Comment from the depositor | |
|---|
| HPS1950 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ossification of the yellow ligament (OYL). |
|---|
| Comment from the depositor | |
|---|
| HPS1951 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ossification of the yellow ligament (OYL). |
|---|
| Comment from the depositor | |
|---|
| HPS1952 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ossification of the yellow ligament (OYL). |
|---|
| Comment from the depositor | |
|---|
| HPS1953 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ossification of the yellow ligament (OYL). |
|---|
| Comment from the depositor | |
|---|
| HPS1954 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hyperprolactinaemia, pituitary adenoma (prolactinoma). |
|---|
| Comment from the depositor | |
|---|
| HPS1955 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hyperprolactinaemia, pituitary adenoma (prolactinoma). |
|---|
| Comment from the depositor | |
|---|
| HPS1956 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hyperprolactinaemia, pituitary adenoma (prolactinoma). |
|---|
| Comment from the depositor | |
|---|
| HPS1957 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hyperprolactinaemia, pituitary adenoma (prolactinoma). |
|---|
| Comment from the depositor | |
|---|
| HPS1958 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hyperprolactinaemia, pituitary adenoma (prolactinoma). |
|---|
| Comment from the depositor | |
|---|
| HPS1959 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hyperprolactinaemia, pituitary adenoma (prolactinoma). |
|---|
| Comment from the depositor | |
|---|
| HPS1960 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of TSH, TSH-secreting pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1961 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of TSH, TSH-secreting pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1962 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of TSH, TSH-secreting pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1963 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of TSH, TSH-secreting pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1964 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of TSH, TSH-secreting pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1965 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pituitary hypersecretion of TSH, TSH-secreting pituitary adenoma. |
|---|
| Comment from the depositor | |
|---|
| HPS1966 |
|
| Comment | Disease specific iPS cell line derived from a patient : Thrombotic thrombocytopenic purpura (TTP). HPS1966, HPS1967, HPS1968, HPS1969, HPS1970, HPS1971 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of thrombotic thrombocytopenic purpura (TTP) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1967 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Thrombotic thrombocytopenic purpura (TTP). |
|---|
| Comment from the depositor | |
|---|
| HPS1968 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Thrombotic thrombocytopenic purpura (TTP). |
|---|
| Comment from the depositor | |
|---|
| HPS1969 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Thrombotic thrombocytopenic purpura (TTP). |
|---|
| Comment from the depositor | |
|---|
| HPS1970 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Thrombotic thrombocytopenic purpura (TTP). |
|---|
| Comment from the depositor | |
|---|
| HPS1971 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Thrombotic thrombocytopenic purpura (TTP). |
|---|
| Comment from the depositor | |
|---|
| HPS1972 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary sclerosing cholangitis (PSC). |
|---|
| Comment from the depositor | |
|---|
| HPS1973 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary sclerosing cholangitis (PSC). |
|---|
| Comment from the depositor | |
|---|
| HPS1974 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary sclerosing cholangitis (PSC). |
|---|
| Comment from the depositor | |
|---|
| HPS1975 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary sclerosing cholangitis (PSC). |
|---|
| Comment from the depositor | |
|---|
| HPS1976 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary sclerosing cholangitis (PSC). |
|---|
| Comment from the depositor | |
|---|
| HPS1977 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Primary sclerosing cholangitis (PSC). |
|---|
| Comment from the depositor | |
|---|
| HPS1978 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinal stenosis. HPS1978, HPS1979, HPS1980, HPS1981 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of spinal stenosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1979 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal stenosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1980 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal stenosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1981 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinal stenosis. |
|---|
| Comment from the depositor | |
|---|
| HPS1982 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lichen sclerosus et atrophicus. |
|---|
| Comment from the depositor | |
|---|
| HPS1983 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lichen sclerosus et atrophicus. |
|---|
| Comment from the depositor | |
|---|
| HPS1984 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lichen sclerosus et atrophicus. |
|---|
| Comment from the depositor | |
|---|
| HPS1985 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lichen sclerosus et atrophicus. |
|---|
| Comment from the depositor | |
|---|
| HPS1986 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lichen sclerosus et atrophicus. |
|---|
| Comment from the depositor | |
|---|
| HPS1987 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lichen sclerosus et atrophicus. |
|---|
| Comment from the depositor | |
|---|
| HPS1988 |
|
| Comment | Disease specific iPS cell line derived from a patient : Relapsing polychondritis (RP). |
|---|
| Comment from the depositor | |
|---|
| HPS1989 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Relapsing polychondritis (RP). |
|---|
| Comment from the depositor | |
|---|
| HPS1990 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Relapsing polychondritis (RP). |
|---|
| Comment from the depositor | |
|---|
| HPS1991 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Relapsing polychondritis (RP). |
|---|
| Comment from the depositor | |
|---|
| HPS1992 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Relapsing polychondritis (RP). |
|---|
| Comment from the depositor | |
|---|
| HPS1993 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Relapsing polychondritis (RP). |
|---|
| Comment from the depositor | |
|---|
| HPS1994 |
|
| Comment | Disease specific iPS cell line derived from a patient : Autoimmune hemolytic anemia (AIHA), idiopathic warm AIHA. HPS1994, HPS1995, HPS1996, HPS1997, HPS1998, HPS1999 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of autoimmune hemolytic anemia (AIHA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS1995 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hemolytic anemia (AHA), idiopathic warm (AHA). |
|---|
| Comment from the depositor | |
|---|
| HPS1996 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hemolytic anemia (AHA), idiopathic warm (AHA). |
|---|
| Comment from the depositor | |
|---|
| HPS1997 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hemolytic anemia (AHA), idiopathic warm (AHA). |
|---|
| Comment from the depositor | |
|---|
| HPS1998 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hemolytic anemia (AHA), idiopathic warm (AHA). |
|---|
| Comment from the depositor | |
|---|
| HPS1999 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Autoimmune hemolytic anemia (AHA), idiopathic warm (AHA). |
|---|
| Comment from the depositor | |
|---|
| HPS2000 |
|
| Comment | Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum, mutation in XPA. HPS2000, HPS2001, HPS2002, HPS2003 HPS2004, HPS2005 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of xeroderma pigmentosum patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2001 |
|
| Comment | Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum, mutation in XPA. HPS2000, HPS2001, HPS2002, HPS2003 HPS2004, HPS2005 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of xeroderma pigmentosum patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2002 |
|
| Comment | Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum, mutation in XPA. HPS2000, HPS2001, HPS2002, HPS2003 HPS2004, HPS2005 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of xeroderma pigmentosum patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2003 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum, mutation in XPA. |
|---|
| Comment from the depositor | |
|---|
| HPS2004 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum, mutation in XPA. |
|---|
| Comment from the depositor | |
|---|
| HPS2005 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Xeroderma pigmentosum, mutation in XPA. |
|---|
| Comment from the depositor | |
|---|
| HPS2006 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital ichthyosis, ichthyosis syndrome. HPS2006, HPS2007, HPS2008, HPS2009, HPS2010, HPS2011 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of congenital ichthyosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2007 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital ichthyosis, ichthyosis syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2008 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital ichthyosis, ichthyosis syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2009 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital ichthyosis, ichthyosis syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2010 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital ichthyosis, ichthyosis syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2011 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital ichthyosis, ichthyosis syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2012 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis (CIPA), unknown genetic etiology. HPS2012, HPS2013, HPS2014, HPS2015, HPS2016, HPS2017 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of congenital insensitivity to pain with anhidrosis (CIPA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2013 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis (CIPA), unknown genetic etiology. HPS2012, HPS2013, HPS2014, HPS2015, HPS2016, HPS2017 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of congenital insensitivity to pain with anhidrosis (CIPA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2014 |
|
| Comment | Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis (CIPA), unknown genetic etiology. HPS2012, HPS2013, HPS2014, HPS2015, HPS2016, HPS2017 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of congenital insensitivity to pain with anhidrosis (CIPA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2015 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis (CIPA), unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2016 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis (CIPA), unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2017 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital insensitivity to pain with anhidrosis (CIPA), unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2018 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic amyloidosis, hereditary amyloidosis. HPS2018, HPS2019, HPS2020, HPS2021, HPS2022, HPS2023 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of systemic amyloidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2019 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, hereditary amyloidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2020 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, hereditary amyloidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2021 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, hereditary amyloidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2022 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, hereditary amyloidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2023 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, hereditary amyloidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2024 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic amyloidosis, AL amyloidosis. HPS2024, HPS2025, HPS2026, HPS2027, HPS2028, HPS2029 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of systemic amyloidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2025 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, AL amyloidosis |
|---|
| Comment from the depositor | |
|---|
| HPS2026 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, AL amyloidosis |
|---|
| Comment from the depositor | |
|---|
| HPS2027 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, AL amyloidosis |
|---|
| Comment from the depositor | |
|---|
| HPS2028 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, AL amyloidosis |
|---|
| Comment from the depositor | |
|---|
| HPS2029 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic amyloidosis, AL amyloidosis |
|---|
| Comment from the depositor | |
|---|
| HPS2030 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hypophosphatasia, mutation in TNSALP. HPS2030, HPS2031, HPS2032, HPS2033, HPS2034, HPS2035 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of hypophosphatasia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2031 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypophosphatasia, mutation in TNSALP. |
|---|
| Comment from the depositor | |
|---|
| HPS2032 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypophosphatasia, mutation in TNSALP. |
|---|
| Comment from the depositor | |
|---|
| HPS2033 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypophosphatasia, mutation in TNSALP. |
|---|
| Comment from the depositor | |
|---|
| HPS2034 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypophosphatasia, mutation in TNSALP. |
|---|
| Comment from the depositor | |
|---|
| HPS2035 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hypophosphatasia, mutation in TNSALP. |
|---|
| Comment from the depositor | |
|---|
| HPS2036 |
|
| Comment | Disease specific iPS cell line derived from a patient : Atypical hemolytic uremic syndrome (aHUS), mutation in factor B. HPS2036, HPS2037, HPS2038, HPS2039, HPS2040, HPS2041 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of atypical hemolytic uremic syndrome (aHUS) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2037 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Atypical hemolytic uremic syndrome (aHUS), mutation in factor B. |
|---|
| Comment from the depositor | |
|---|
| HPS2038 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Atypical hemolytic uremic syndrome (aHUS), mutation in factor B. |
|---|
| Comment from the depositor | |
|---|
| HPS2039 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Atypical hemolytic uremic syndrome (aHUS), mutation in factor B. |
|---|
| Comment from the depositor | |
|---|
| HPS2040 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Atypical hemolytic uremic syndrome (aHUS), mutation in factor B. |
|---|
| Comment from the depositor | |
|---|
| HPS2041 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Atypical hemolytic uremic syndrome (aHUS), mutation in factor B. |
|---|
| Comment from the depositor | |
|---|
| HPS2048 |
|
| Comment | Disease specific iPS cell line derived from a patient : Hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology. HPS2048, HPS2049, HPS2050, HPS2051, HPS2052, HPS2053 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of hemiconvulsion-hemiplegia-epilepsy syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2049 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2050 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2051 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2052 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2053 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2054 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crohn's disease, ileocolic type. HPS2054, HPS2055, HPS2056, HPS2057, HPS2058, HPS2059 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crohn's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2055 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crohn's disease, ileocolic type. HPS2054, HPS2055, HPS2056, HPS2057, HPS2058, HPS2059 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crohn's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2056 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crohn's disease, ileocolic type. HPS2054, HPS2055, HPS2056, HPS2057, HPS2058, HPS2059 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crohn's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2057 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crohn's disease, ileocolic type. |
|---|
| Comment from the depositor | |
|---|
| HPS2058 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crohn's disease, ileocolic type. |
|---|
| Comment from the depositor | |
|---|
| HPS2059 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crohn's disease, ileocolic type. |
|---|
| Comment from the depositor | |
|---|
| HPS2060 |
|
| Comment | Disease specific iPS cell line derived from a patient : Behcet's disease, neuro-Behcet's disease/ HLA-B51. HPS2060, HPS2061, HPS2062, HPS2063, HPS2064, HPS2065 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Behcet disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2061 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, neuro-Behcet's disease/ HLA-B51. |
|---|
| Comment from the depositor | |
|---|
| HPS2062 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, neuro-Behcet's disease/ HLA-B51. |
|---|
| Comment from the depositor | |
|---|
| HPS2063 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, neuro-Behcet's disease/ HLA-B51. |
|---|
| Comment from the depositor | |
|---|
| HPS2064 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, neuro-Behcet's disease/ HLA-B51. |
|---|
| Comment from the depositor | |
|---|
| HPS2065 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Behcet's disease, neuro-Behcet's disease/ HLA-B51. |
|---|
| Comment from the depositor | |
|---|
| HPS2066 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2067 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2068 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2069 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2070 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2071 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Moyamoya disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2072 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, mixed type. |
|---|
| Comment from the depositor | |
|---|
| HPS2073 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, mixed type. |
|---|
| Comment from the depositor | |
|---|
| HPS2074 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, mixed type. |
|---|
| Comment from the depositor | |
|---|
| HPS2075 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, mixed type. |
|---|
| Comment from the depositor | |
|---|
| HPS2076 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, mixed type. |
|---|
| Comment from the depositor | |
|---|
| HPS2077 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Takayasu arteritis, mixed type. |
|---|
| Comment from the depositor | |
|---|
| HPS2078 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita), BP180 antibody positive. |
|---|
| Comment from the depositor | |
|---|
| HPS2079 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita), BP180 antibody positive. |
|---|
| Comment from the depositor | |
|---|
| HPS2080 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita), BP180 antibody positive. |
|---|
| Comment from the depositor | |
|---|
| HPS2081 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita), BP180 antibody positive. |
|---|
| Comment from the depositor | |
|---|
| HPS2082 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita), BP180 antibody positive. |
|---|
| Comment from the depositor | |
|---|
| HPS2083 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pemphigoid (including epidermolysis bullosa acquisita), BP180 antibody positive. |
|---|
| Comment from the depositor | |
|---|
| HPS2084 |
|
| Comment | Disease specific iPS cell line derived from a patient : Angelman syndrome, deletion of 15q11.2-15q11.3. HPS2084, HPS2085, HPS2086, HPS2087, HPS2088, HPS2089 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of angelman syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2085 |
|
| Comment | Disease specific iPS cell line derived from a patient : Angelman syndrome, deletion of 15q11.2-15q11.3. HPS2084, HPS2085, HPS2086, HPS2087, HPS2088, HPS2089 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of angelman syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2086 |
|
| Comment | Disease specific iPS cell line derived from a patient : Angelman syndrome, deletion of 15q11.2-15q11.3. HPS2084, HPS2085, HPS2086, HPS2087, HPS2088, HPS2089 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of angelman syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2087 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Angelman syndrome, deletion of 15q11.2-15q11.3. |
|---|
| Comment from the depositor | |
|---|
| HPS2088 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Angelman syndrome, deletion of 15q11.2-15q11.3. |
|---|
| Comment from the depositor | |
|---|
| HPS2089 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Angelman syndrome, deletion of 15q11.2-15q11.3. |
|---|
| Comment from the depositor | |
|---|
| HPS2090 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2091 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2092 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2093 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2094 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2095 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Sarcoidosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2096 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dravet syndrome, mutation of SCN1A. HPS2096, HPS2097, HPS2098, HPS2099, HPS2100, HPS2101 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Dravet syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2097 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dravet syndrome, mutation of SCN1A. HPS2096, HPS2097, HPS2098, HPS2099, HPS2100, HPS2101 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Dravet syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2098 |
|
| Comment | Disease specific iPS cell line derived from a patient : Dravet syndrome, mutation of SCN1A. HPS2096, HPS2097, HPS2098, HPS2099, HPS2100, HPS2101 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Dravet syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2099 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dravet syndrome, mutation of SCN1A. |
|---|
| Comment from the depositor | |
|---|
| HPS2100 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dravet syndrome, mutation of SCN1A. |
|---|
| Comment from the depositor | |
|---|
| HPS2101 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Dravet syndrome, mutation of SCN1A. |
|---|
| Comment from the depositor | |
|---|
| HPS2102 |
|
| Comment | Disease specific iPS cell line derived from a patient : Buerger's disease. HPS2102, HPS2103, HPS2104, HPS2105, HPS2106, HPS2107 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Buerger's disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2103 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2104 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2105 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2106 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2107 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Buerger's disease. |
|---|
| Comment from the depositor | |
|---|
| HPS2108 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, symptomatic heterozygote / unknown genetic etiology). HPS2108, HPS2109, HPS2110, HPS2111, HPS2112, HPS2113 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Fabry disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2109 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, symptomatic heterozygote / unknown genetic etiology). HPS2108, HPS2109, HPS2110, HPS2111, HPS2112, HPS2113 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Fabry disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2110 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, symptomatic heterozygote / unknown genetic etiology). HPS2108, HPS2109, HPS2110, HPS2111, HPS2112, HPS2113 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Fabry disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2111 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, symptomatic heterozygote / unknown genetic etiology). |
|---|
| Comment from the depositor | |
|---|
| HPS2112 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, symptomatic heterozygote / unknown genetic etiology). |
|---|
| Comment from the depositor | |
|---|
| HPS2113 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (Fabry disease, symptomatic heterozyg0te / unknown genetic etiology). |
|---|
| Comment from the depositor | |
|---|
| HPS2114 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, TSC-LAM. HPS2114, HPS2115, HPS2116 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS2115 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, TSC-LAM. HPS2114, HPS2115, HPS2116 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS2116 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, TSC-LAM. HPS2114, HPS2115, HPS2116 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS2117 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, TSC-LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS2118 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, TSC-LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS2119 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lymphangioleiomyomatosis, TSC-LAM. |
|---|
| Comment from the depositor | |
|---|
| HPS2120 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS), inverted duplication of chromosome 15. HPS2120, HPS2121, HPS2122, HPS2123, HPS2124, HPS2125 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Lennox-Gastaut syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2121 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS), inverted duplication of chromosome 15. HPS2120, HPS2121, HPS2122, HPS2123, HPS2124, HPS2125 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Lennox-Gastaut syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2122 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS), inverted duplication of chromosome 15. HPS2120, HPS2121, HPS2122, HPS2123, HPS2124, HPS2125 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Lennox-Gastaut syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2123 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS), inverted duplication of chromosome 15. |
|---|
| Comment from the depositor | |
|---|
| HPS2124 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS), inverted duplication of chromosome 15. |
|---|
| Comment from the depositor | |
|---|
| HPS2125 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lennox-Gastaut syndrome (LGS), inverted duplication of chromosome 15. |
|---|
| Comment from the depositor | |
|---|
| HPS2126 |
|
| Comment | Disease specific iPS cell line derived from a patient : Distal myopathy, DMRV / GNE myopathy. HPS2126, HPS2127, HPS2128, HPS2129, HPS2130, HPS2131 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of distal myopathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2127 |
|
| Comment | Disease specific iPS cell line derived from a patient : Distal myopathy, DMRV / GNE myopathy. HPS2126, HPS2127, HPS2128, HPS2129, HPS2130, HPS2131 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of distal myopathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2128 |
|
| Comment | Disease specific iPS cell line derived from a patient : Distal myopathy, DMRV / GNE myopathy. HPS2126, HPS2127, HPS2128, HPS2129, HPS2130, HPS2131 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of distal myopathy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2129 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS2130 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS2131 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Distal Myopathy, DMRV / GNE myopathy. |
|---|
| Comment from the depositor | |
|---|
| HPS2132 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, suspect of central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS2133 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, suspect of central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS2134 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, suspect of central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS2135 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, suspect of central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS2136 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, suspect of central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS2137 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Disorders of pituitary ADH secretion, suspect of central diabetes insipidus. |
|---|
| Comment from the depositor | |
|---|
| HPS2138 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS2138, HPS2139, HPS2140, HPS2141, HPS2142, HPS2143 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2139 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS2138, HPS2139, HPS2140, HPS2141, HPS2142, HPS2143 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2140 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS2138, HPS2139, HPS2140, HPS2141, HPS2142, HPS2143 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2141 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS2138, HPS2139, HPS2140, HPS2141, HPS2142, HPS2143 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2142 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS1269 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2143 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ring chromosome 20 syndrome. HPS2138, HPS2139, HPS2140, HPS2141, HPS2142, HPS2143 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ring chromosome 20 syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2144 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2145 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2146 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2147 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2148 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2149 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2150 |
|
| Comment | Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2151 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2152 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2153 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2154 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2155 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic granulomatosis with polyangiitis (EGPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2156 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neuronal migration disorder, polymicrogyria / unknown genetic etiology. HPS2156, HPS2157, HPS2158, HPS2159, HPS2160, HPS2161 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of neuronal migration disorder patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2157 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neuronal migration disorder, polymicrogyria / unknown genetic etiology. HPS2156, HPS2157, HPS2158, HPS2159, HPS2160, HPS2161 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of neuronal migration disorder patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2158 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, polymicrogyria / unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2159 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, polymicrogyria / unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2160 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, polymicrogyria / unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2161 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neuronal migration disorder, polymicrogyria / unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2162 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-hydroxylase deciciency / salt-wasting form. |
|---|
| Comment from the depositor | |
|---|
| HPS2163 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-hydroxylase deciciency / salt-wasting form. |
|---|
| Comment from the depositor | |
|---|
| HPS2164 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-hydroxylase deciciency / salt-wasting form. |
|---|
| Comment from the depositor | |
|---|
| HPS2165 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-hydroxylase deciciency / salt-wasting form. |
|---|
| Comment from the depositor | |
|---|
| HPS2166 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-hydroxylase deciciency / salt-wasting form. |
|---|
| Comment from the depositor | |
|---|
| HPS2167 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Congenital Adrenal enzyme deficiency, 21-hydroxylase deciciency / salt-wasting form. |
|---|
| Comment from the depositor | |
|---|
| HPS2168 |
|
| Comment | Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). HPS2168, HPS2169, HPS2170, HPS2171, HPS2172, HPS2173 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of systemic sclerosis (SSc) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2169 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS2170 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS2171 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS2172 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS2173 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Systemic sclerosis (SSc). |
|---|
| Comment from the depositor | |
|---|
| HPS2174 |
|
| Comment | Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP) / multifocal motor neuropathy (MMN), sensory. HPS2174, HPS2175, HPS2176, HPS2177, HPS2178, HPS2179 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of chronic inflammatory demyelinating polyneuropathy (CIDP) / multifocal motor neuropathy (MMN) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2175 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP). |
|---|
| Comment from the depositor | |
|---|
| HPS2176 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP). |
|---|
| Comment from the depositor | |
|---|
| HPS2177 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP). |
|---|
| Comment from the depositor | |
|---|
| HPS2178 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP). |
|---|
| Comment from the depositor | |
|---|
| HPS2179 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Chronic inflammatory demyelinating polyneuropathy (CIDP). |
|---|
| Comment from the depositor | |
|---|
| HPS2180 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis, Part A. |
|---|
| Comment from the depositor | |
|---|
| HPS2181 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis, Part A. |
|---|
| Comment from the depositor | |
|---|
| HPS2182 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis, Part A. |
|---|
| Comment from the depositor | |
|---|
| HPS2183 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis, Part A. |
|---|
| Comment from the depositor | |
|---|
| HPS2184 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis, Part A. |
|---|
| Comment from the depositor | |
|---|
| HPS2185 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Rasmussen encephalitis, Part A. |
|---|
| Comment from the depositor | |
|---|
| HPS2186 |
|
| Comment | Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2187 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2188 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2189 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2190 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2191 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Granulomatosis with polyangiitis (GPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2192 |
|
| Comment | Disease specific iPS cell line derived from a patient : Polycystic Kidney disease (ADPKD). HPS2192, HPS2193, HPS2194, HPS2195, HPS2196, HPS2197 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of polycystic Kidney disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2193 |
|
| Comment | Disease specific iPS cell line derived from a patient : Polycystic Kidney disease (ADPKD). HPS2192, HPS2193, HPS2194, HPS2195, HPS2196, HPS2197 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of polycystic Kidney disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2194 |
|
| Comment | Disease specific iPS cell line derived from a patient : Polycystic Kidney disease (ADPKD). HPS2192, HPS2193, HPS2194, HPS2195, HPS2196, HPS2197 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of polycystic Kidney disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2195 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polycystic Kidney disease (ADPKD). |
|---|
| Comment from the depositor | |
|---|
| HPS2196 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polycystic Kidney disease (ADPKD). |
|---|
| Comment from the depositor | |
|---|
| HPS2197 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polycystic Kidney disease (ADPKD). |
|---|
| Comment from the depositor | |
|---|
| HPS2198 |
|
| Comment | Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS2199 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS2200 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS2201 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure type. |
|---|
| Comment from the depositor | |
|---|
| HPS2202 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS2203 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS2204 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS2205 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS2206 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS2207 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension. |
|---|
| Comment from the depositor | |
|---|
| HPS2208 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2209 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2210 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2211 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2212 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2213 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : 5p-syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2214 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS2214, HPS2215, HPS2216, HPS2217, HPS2218, HPS2219 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple system atrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2215 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS2214, HPS2215, HPS2216, HPS2217, HPS2218, HPS2219 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple system atrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2216 |
|
| Comment | Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). HPS2214, HPS2215, HPS2216, HPS2217, HPS2218, HPS2219 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of multiple system atrophy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2217 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS2218 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS2219 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). |
|---|
| Comment from the depositor | |
|---|
| HPS2220 |
|
| Comment | Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. |
|---|
| Comment from the depositor | |
|---|
| HPS2221 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. |
|---|
| Comment from the depositor | |
|---|
| HPS2222 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. |
|---|
| Comment from the depositor | |
|---|
| HPS2223 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. |
|---|
| Comment from the depositor | |
|---|
| HPS2224 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. |
|---|
| Comment from the depositor | |
|---|
| HPS2225 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. |
|---|
| Comment from the depositor | |
|---|
| HPS2226 |
|
| Comment | Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration, sporadic. |
|---|
| Comment from the depositor | |
|---|
| HPS2227 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration, sporadic. |
|---|
| Comment from the depositor | |
|---|
| HPS2228 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration, sporadic. |
|---|
| Comment from the depositor | |
|---|
| HPS2229 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration, sporadic. |
|---|
| Comment from the depositor | |
|---|
| HPS2230 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration, sporadic. |
|---|
| Comment from the depositor | |
|---|
| HPS2231 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration, sporadic. |
|---|
| Comment from the depositor | |
|---|
| HPS2232 |
|
| Comment | Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, empty sella syndrome. HPS2232, HPS2233, HPS2234, HPS2235, HPS2236, HPS2237 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of anterior pituitary hypofunction patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2233 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, empty sella syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2234 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, empty sella syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2235 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, empty sella syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2236 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, empty sella syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2237 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Anterior pituitary hypofunction, empty sella syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2238 |
|
| Comment | Disease specific iPS cell line derived from a patient :Isaacs syndrome. HPS2238, HPS2239, HPS2240, HPS2241, HPS2242, HPS2243 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Isaacs syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2239 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient :Isaacs syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2240 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient :Isaacs syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2241 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient :Isaacs syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2242 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient :Isaacs syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2243 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient :Isaacs syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2244 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA). |
|---|
| Comment from the depositor | |
|---|
| HPS2245 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA). |
|---|
| Comment from the depositor | |
|---|
| HPS2246 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA). |
|---|
| Comment from the depositor | |
|---|
| HPS2247 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA). |
|---|
| Comment from the depositor | |
|---|
| HPS2248 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA). |
|---|
| Comment from the depositor | |
|---|
| HPS2249 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Giant cell arteritis (GCA). |
|---|
| Comment from the depositor | |
|---|
| HPS2250 |
|
| Comment | Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS2251 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS2252 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS2253 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS2254 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS2255 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Neurofibromatosis type1 (NF1). |
|---|
| Comment from the depositor | |
|---|
| HPS2256 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN). |
|---|
| Comment from the depositor | |
|---|
| HPS2257 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN). |
|---|
| Comment from the depositor | |
|---|
| HPS2258 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN). |
|---|
| Comment from the depositor | |
|---|
| HPS2259 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN). |
|---|
| Comment from the depositor | |
|---|
| HPS2260 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN). |
|---|
| Comment from the depositor | |
|---|
| HPS2261 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Polyarteritis nodosa (PAN). |
|---|
| Comment from the depositor | |
|---|
| HPS2262 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2263 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2264 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2265 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2266 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2267 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Refractory nephrotic syndrome. |
|---|
| Comment from the depositor | |
|---|
| HPS2268 |
|
| Comment | Disease specific iPS cell line derived from a patient : Eosinophilic gastro-intestinal disorder, eosinophilic gastroenteritis. HPS2268, HPS2269, HPS2270, HPS2271, HPS2272, HPS2273 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of eosinophilic gastro-intestinal disorder patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2269 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic gastro-intestinal disorder, eosinophilic gastroenteritis. |
|---|
| Comment from the depositor | |
|---|
| HPS2270 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic gastro-intestinal disorder, eosinophilic gastroenteritis. |
|---|
| Comment from the depositor | |
|---|
| HPS2271 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic gastro-intestinal disorder, eosinophilic gastroenteritis. |
|---|
| Comment from the depositor | |
|---|
| HPS2272 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic gastro-intestinal disorder, eosinophilic gastroenteritis. |
|---|
| Comment from the depositor | |
|---|
| HPS2273 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Eosinophilic gastro-intestinal disorder, eosinophilic gastroenteritis. |
|---|
| Comment from the depositor | |
|---|
| HPS2274 |
|
| Comment | Disease specific iPS cell line derived from a patient : neurofibromatosis type 2 (NF2). |
|---|
| Comment from the depositor | |
|---|
| HPS2275 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : neurofibromatosis type 2 (NF2). |
|---|
| Comment from the depositor | |
|---|
| HPS2276 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : neurofibromatosis type 2 (NF2). |
|---|
| Comment from the depositor | |
|---|
| HPS2277 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : neurofibromatosis type 2 (NF2). |
|---|
| Comment from the depositor | |
|---|
| HPS2278 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : neurofibromatosis type 2 (NF2). |
|---|
| Comment from the depositor | |
|---|
| HPS2279 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : neurofibromatosis type 2 (NF2). |
|---|
| Comment from the depositor | |
|---|
| HPS2280 |
|
| Comment | Disease specific iPS cell line derived from a patient : Progressive multifocal leukoencephalopathy (PML). HPS2280, HPS2281, HPS2282, HPS2283, HPS2284 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Progressive multifocal leukoencephalopathy (PML) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2281 |
|
| Comment | Currently not ready. isease specific iPS cell line derived from a patient : Progressive multifocal leukoencephalopathy (PML). |
|---|
| Comment from the depositor | |
|---|
| HPS2282 |
|
| Comment | Currently not ready. isease specific iPS cell line derived from a patient : Progressive multifocal leukoencephalopathy (PML). |
|---|
| Comment from the depositor | |
|---|
| HPS2283 |
|
| Comment | Currently not ready. isease specific iPS cell line derived from a patient : Progressive multifocal leukoencephalopathy (PML). |
|---|
| Comment from the depositor | |
|---|
| HPS2284 |
|
| Comment | Currently not ready. isease specific iPS cell line derived from a patient : Progressive multifocal leukoencephalopathy (PML). |
|---|
| Comment from the depositor | |
|---|
| HPS2285 |
|
| Comment | Disease specific iPS cell line derived from a patient : Syringomyelia. HPS2285, HPS2286, HPS2287, HPS2288, HPS2289 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of syringomyelia patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2286 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Syringomyelia. |
|---|
| Comment from the depositor | |
|---|
| HPS2287 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Syringomyelia. |
|---|
| Comment from the depositor | |
|---|
| HPS2288 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Syringomyelia. |
|---|
| Comment from the depositor | |
|---|
| HPS2289 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Syringomyelia. |
|---|
| Comment from the depositor | |
|---|
| HPS2290 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2291 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2292 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2293 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2294 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2295 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Pulmonary veno-occlusive disease / pulmonary capillary hemangiomatosis. |
|---|
| Comment from the depositor | |
|---|
| HPS2296 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. The analysis performed by RIKEN BRC indicated hemizygous deletion of 18,917,031_21,462,658 in 22q11.21 region (detected by CGH array). HPS2296, HPS2297, HPS2298, HPS2299, HPS2300 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2297 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS2296, HPS2297, HPS2298, HPS2299, HPS2300 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2298 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS2296, HPS2297, HPS2298, HPS2299, HPS2300 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2299 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS2296, HPS2297, HPS2298, HPS2299, HPS2300 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2300 |
|
| Comment | Disease specific iPS cell line derived from a patient : 22q11.2 deletion syndrome. HPS2296, HPS2297, HPS2298, HPS2299, HPS2300 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of 22q11.2 deletion syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2301 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, type 4 / mutation in COL3A1. HPS2301, HPS2302, HPS2303, HPS2304, HPS2305, HPS2306 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ehlers-Danlos syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2302 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, type 4 / mutation in COL3A1. HPS2301, HPS2302, HPS2303, HPS2304, HPS2305, HPS2306 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ehlers-Danlos syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2303 |
|
| Comment | Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, type 4 / mutation in COL3A1. HPS2301, HPS2302, HPS2303, HPS2304, HPS2305, HPS2306 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Ehlers-Danlos syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2304 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, type 4 / mutation in COL3A1. |
|---|
| Comment from the depositor | |
|---|
| HPS2305 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, type 4 / mutation in COL3A1. |
|---|
| Comment from the depositor | |
|---|
| HPS2306 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, type 4 / mutation in COL3A1. |
|---|
| Comment from the depositor | |
|---|
| HPS2307 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. HPS2308 and HPS2309 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS2308 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. HPS2307 and HPS2309 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS2309 |
|
| Comment | Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. HPS2307 and HPS2308 were derived from the same patient. |
|---|
| Comment from the depositor | |
|---|
| HPS2310 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. |
|---|
| Comment from the depositor | |
|---|
| HPS2311 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. |
|---|
| Comment from the depositor | |
|---|
| HPS2312 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Idiopathic thrombocytopenic purpura. |
|---|
| Comment from the depositor | |
|---|
| HPS2313 |
|
| Comment | Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. HPS2313, HPS2314, HPS2315 HPS2316, HPS2317, HPS2318 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of PCDH19 epilepsy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2314 |
|
| Comment | Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. HPS2313, HPS2314, HPS2315 HPS2316, HPS2317, HPS2318 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of PCDH19 epilepsy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2315 |
|
| Comment | Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. HPS2313, HPS2314, HPS2315 HPS2316, HPS2317, HPS2318 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of PCDH19 epilepsy patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2316 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. |
|---|
| Comment from the depositor | |
|---|
| HPS2317 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. |
|---|
| Comment from the depositor | |
|---|
| HPS2318 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : PCDH19 epilepsy, PCDH19 mutation. |
|---|
| Comment from the depositor | |
|---|
| HPS2319 |
|
| Comment | Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). HPS2319, HPS2320, HPS2321, HPS2322, HPS2323, HPS2324 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of epilepsy with myoclonic absence (EMA) patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2320 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS2321 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS2322 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS2323 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS2324 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with myoclonic absence (EMA). |
|---|
| Comment from the depositor | |
|---|
| HPS2325 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2326 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2327 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2328 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2329 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2330 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Microscopic polyangiitis (MPA). |
|---|
| Comment from the depositor | |
|---|
| HPS2331 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2332 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2333 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2334 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2335 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2336 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Epilepsy with continuous spikes and waves during slow sleep, unknown genetic etiology. |
|---|
| Comment from the depositor | |
|---|
| HPS2337 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). HPS2337, HPS2338, HPS2339, HPS2340 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of GM1-gangliosidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2338 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). HPS2337, HPS2338, HPS2339, HPS2340 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of GM1-gangliosidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2339 |
|
| Comment | Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). HPS2337, HPS2338, HPS2339, HPS2340 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of GM1-gangliosidosis patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2340 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Lysosomal storage disease (GM1-gangliosidosis). |
|---|
| Comment from the depositor | |
|---|
| HPS2341 |
|
| Comment | Disease specific iPS cell line derived from a patient : Alexander disease, type 2. HPS2341, HPS2342, HPS2343, HPS2344, HPS2345, HPS2346 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Alexander disease patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2342 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS2343 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS2344 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS2345 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS2346 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Alexander disease, type 2. |
|---|
| Comment from the depositor | |
|---|
| HPS2347 |
|
| Comment | Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome, possible CFS. HPS2347, HPS2348, HPS2349, HPS2350, HPS2351, HPS2352 were derived from the same patient. |
|---|
| Comment from the depositor | Disease-specific iPS cells. iPS cells were established from the peripheral blood mononuclear cells of Crow-Fukase syndrome patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
|---|
| HPS2348 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome, possible CFS. |
|---|
| Comment from the depositor | |
|---|
| HPS2349 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome, possible CFS. |
|---|
| Comment from the depositor | |
|---|
| HPS2350 |
|
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Crow-Fukase syndrome, possible CFS. |
|---|
| Comment from the depositor | |
|---|
|